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CHAPTER 1: INTRODUCTION AND BACKGROUND
Prevalence and Significance of Peripheral Nerve Injuries
Trauma is the most common cause of peripheral nerve injuries (PNI) comprising nearly
3% of all traumatic injuries in the United States. In combat, however, PNI comprises up to 30% of
injuries to the extremities.1-3 Drug regimens (e.g. chemotherapy) and disease (e.g. diabetes) present additional causes of PNI, bringing the potential number of affected patients into the millions.4
In 2012, the number of PNI surgical procedures in the United States was estimated at 560,000
and the market for PNI repair was estimated at $1.3-1.9 billion.5
All peripheral nerves have the potential to regenerate, even following complete nerve transection, if the gap between the two nerve ends is short.6 As the gap length exceeds a critical size
of ~3cm, however, the intrinsic regeneration process becomes delayed or deficient requiring surgical treatment. Current treatments (e.g. coaptation, grafting, and nerve guide conduits) are either
unavailable or insufficient to achieve full functional recovery in large (>3cm) peripheral nerve
gaps. PNI recovery diminishes with each additional centimeter of separation in a transected
nerve. Failed recovery may come at the cost of life-long morbidity, paralysis, and/or vulnerability
to other risks.
This thesis focuses on understanding the complex molecular and cellular environment
that develops following PNI, including the presence of inhibitory signaling molecules and inflammatory cell responses. This thesis explores the use of different tissue engineering strategies to
direct the behavior and phenotype not only of neurons, but glia (Schwann cells) and immune cells
(macrophages). The overall hypothesis is that biomaterials-based adhesive and topographical
cues, designed to mimic the innate regenerative capacity in short injuries, can be used to accelerate regeneration and repair. The strategies explored here can ultimately help improve the design of treatments for large PNI. To understand the complexity of the PNI environment, a detailed
description of peripheral nerve anatomy and physiology follows.
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Nerve Anatomy and Physiology
The human nervous system is divided into the central nervous system (CNS), composed
of the spinal cord and brain, and is connected to the rest of the body by the peripheral nervous
system (PNS). Communication between the PNS and CNS is coordinated by neurons, the major
cell type of the nervous system. The PNS is composed of two types of neurons. Motor neurons
transmit signals from their cell bodies in the spinal cord out to distant target organs.7 Alternatively,
sensory neurons transmit signals from their cell bodies in the periphery towards the spinal cord
to synapse with central neurons. Neurons transmit these signals via long cytoplasmic extensions,
called axons. Most axons are wrapped in an insulating coating, called the myelin sheath, which
allows for faster conduction of nerve impulses compared to unmyelinated axons.8
In the PNS, myelin sheath is produced by Schwann cells specifically associated with individual axons. Schwann cells are non-neuronal, supportive glial cells making up approximately
80% of the cells in adult peripheral nerves.9 The Schwann cells are surrounded by a thin, continuous layer of basal lamina (mostly collagen fibrils and a few fibroblasts), called the endoneurium.
Non-myelinated axons are embedded directly within Schwann cell cytoplasm.10
Axons, and their Schwann cells, are arranged in motor and sensory bundles, called nerve
fascicles, which are separated by another connective tissue layer called the perineurium. The
perineurium consists of many longitudinally aligned collagen fibrils and layers of flattened perineurial cells.11 Finally, the epineurium is the outermost layer of connective tissue which holds
many fascicles, as well as loose connective tissue, adipose tissue, and blood vessels together
into a whole nerve.
Peripheral Nerve Injury Classifications
In the 1940s, a British orthopedic surgeon, Sir Herbert Seddon, offered the earliest classifications of nerve injury. He described three nerve injury grades: neurapraxia, axonotmesis, and
neurotmesis, each defined by increasing severity of axon and connective tissue layer damage. In
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1951, Australian professor of anatomy and neurology, Sydney Sunderland, used histological sections to expand these classifications into injury grades I through V. Table 1-1 combines Seddon
and Sunderland's work. The remainder of this thesis will discuss strategies specifically aimed at
improving nerve regeneration following complete transection injuries (neurotmesis; grade V) that
result in large nerve gaps (>3cm) for which spontaneous recovery is impossible and surgical interventions still fail to produce full functional recovery.

Seddon

Sunderl
and

Typical
Etiology

Injured
Tissues

Injury
Characteristics

Spontaneous
Recovery
Potential

Neurapraxia

I

Compression
Injury

Myelin

Axon intact,
conduction block

Full; weeks to
months

Full; 2 to 4
months

II

Crush Injury

Myelin, axon

Axon
discontinuity,
conduction
failure

Axonotmesis/
Neurotmesis

III

Transection
Injury

Myelin, axon,
endoneurium

Nerve is still
continuous, tissue
stiffening and
enlargement

Slow,
incomplete

Axonotmesis/
Neurotmesis

IV

Transection
Injury

Myelin, axon,
endoneurium,
perineurium

Same as III +
fascicle damage

Poor without
surgical
intervention

Neurotmesis

V

Transection
Injury

Myelin, axon,
endoneurium,
perineurium,
epineurium

Same as IV +
substantial
hemorrhaging
and scarring

None without
surgical
intervention

Axonotmesis

Injury Schematic

Table 1-1. Peripheral Nerve Injury Grades
The severity of PNI increases from grades I-V. The table defines the tissue layers involved and the
probable clinical outcomes for each class of injury.

Characterization of the Peripheral Nerve Injury Microenvironment
Following peripheral neurotmesis, a cascade of degenerative cellular and molecular
changes occurs at the site of injury.
Neuronal Responses
In the proximal nerve stump (part of the axon still connected to the neuron's cell body),
neurons undergo morphological changes to allow for intrinsic regeneration, most importantly, the
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reformation of the growth cone (Figure 1-1). The growth cone is a specialized structure at the tip
of an advancing axon primarily comprised of actin filaments and microtubules. Growth cones are
highly motile structures that explore the extracellular environment using sheet-like (lamellipodia)
and finger-like (filopodia) extensions to sense biochemical and physical guidance cues. Growth
cones are thus responsible for determining in which direction to grow and then must guide the
axon in that direction.12
dendrites
nucleus
cell body
(soma)

microtubules

actin-myosin
meshwork

actin
filaments

axon/neurite

lamellipodia

growth
cone

filopodia

direction of
outgrowth

Figure 1-1. The growth cone
Schematic representation of a neuron and detailed view of the growth cone with its main
cytoskeletal components.

The growth cone is responsible for mediating axon extension during normal embryonic
development and following injury. In both instances, axon extension occurs through a well-defined
three-step process: 1) protrusion and attachment of filopodia to a substrate, 2) engorgement of
the growth cone by microtubules and organelles, and 3) consolidation of a new stretch of axon
shaft behind the advancing growth cone.13 The three stages of growth cone advance are all influenced by environmental factors, namely adhesive cues in the surrounding matrix. Growth cone
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receptors bind to an adhesive substrate initiating intracellular signaling cascades to further anchor
the cell cytoskeleton to the surface and advance the neurite outgrowth in a rate controlled manner.14
During the development and differentiation of the nervous system axons extend over exceedingly long distances (>1 meter).15, 16 This development involves periods of axon elongation,
retraction, and branching. Neurons extend processes in an excessive and redundant manner.
Thus, some of these branches require selective removal to achieve a final organized and complex
circuitry.17 This removal of aberrant processes, called pruning, is important for proper nervous
system development.18 Within the first 2 days following injury, axons in the proximal stump also
produce many sprouts or branches, from the terminal axon tip, that advance distally. However,
most of these sprouts never make reconnections across the gap but rather undergo periods of
extensive degeneration and retraction.19
Axon degeneration can occur as the result of several different physiological or pathological
conditions. Some causes of degeneration include Wallerian degeneration (distal nerve stump retraction following transection, described next), toxic agent insult, trophic factor deprivation, and
neurodegenerative disease.17, 19 The father of modern neuroscience, Santiago Ramon y Cajal,
was first to describe both long distance retraction, called "resorption," and the pathological morphology of retracting growth cones (he called them "sterile clubs").20 In general, retracting growth
cones have a smooth terminal bulb, while elongating growth cones are ruffled with filopodial extensions.21 Retracting axon shafts can assume different morphologies including bead-like spherical blebbing or retracting as a sinusoidal curve.22 One primary goal of this work was to reduce
neurite retraction events using a novel, tissue engineered construct featuring topographical and
adhesive, biochemical cues for guidance of the growth cones.
In the distal nerve stump (part of the axon separated from the neuron's cell body), axons
undergo widespread disintegration of their cytoskeleton and internal organelles, primarily due to
the lack of trophic support from the soma. This process is called Wallerian degeneration (WD),
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after British physiologist, Augustus Volney Waller, who first described the phenomenon in the
mid- 1800s. The first few hours of WD involve neurofilament break up and axonal fragmentation.
Next the myelin sheath begins to break down into droplets over a few days, with complete denaturation of the myelin after a few weeks. Despite its seemingly catastrophic nature, this type of
axonal degeneration is a normal part of the repair process, primarily because axonal breakdown
initiates a pro-healing response from Schwann cells and macrophages in the injury site.
Glial and Immune Cell Responses
Following PNI, Schwann cells undergo a process, often referred to as de-differentiation,
assuming the phenotype and gene expression of immature, pre-myelinating cells.9 These postinjury Schwann cells also begin to hyperproliferate in response to myelin and axonal debris and
the loss of physical axonal contact. Proliferating Schwann cells migrate along residual basement
membrane forming longitudinal, cellular columns called the Bands of Bungner. These bands serve
as cellular “bridges” that span the nerve gap and provide a substrate for regenerating axons.
Schwann cells further support axon regeneration by depositing extracellular matrix (ECM) proteins and secreting neurotrophic factors (e.g. nerve growth factor, NGF). However, Schwann cells
also express chondroitin sulfate proteoglycans (CSPGs) following injury, which are traditionally
studied as physical and chemical inhibitors to axon regeneration in the CNS, but have more recently been discovered to inhibit axon outgrowth following PNI as well.
Denervated Schwann cells play an early role in removing this debris from the injury site
and are the major phagocytic cells for the first few days after injury. 23 In additional to releasing
factors for neuronal growth and survival, Schwann cells also release cytokines to recruit circulating macrophages to the injury site. Macrophages phagocytose myelin debris during the later
stages of Wallerian degeneration. Macrophages are not only essential for effective myelin phagocytosis but also produce mitogenic factors for Schwann cell activation. Macrophages have even
been shown to stabilize neurite outgrowth from dorsal root ganglia grown on pre-injured nerve
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cryosections24 and can remodel the distal nerve's ECM in preparation to receive the re-growing
axons.23
Following less severe nerve injuries (Sunderland classifications I-III) or in very short nerve
gaps, growth cones that extend into the defect site along the Bands of Bungner will eventually
restore axon-Schwann cell contact. These renewed cell-cell interactions trigger the Schwann cells
to 're-differentiate' and begin remyelinating the newly formed nerve fibers. Macrophage contact
with this 'new' myelin can trigger the immune cells' exit from injury site and re-entry into circulation.
Thus, interactions between Schwann cells and macrophages are imperative for this 'normal' peripheral nerve regeneration to proceed (Figure 1-2).
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Figure 1-2. Typical repair schema following peripheral nerve injury
The “normal” regeneration program that proceeds in short peripheral nerve gaps includes dedifferentiatoin, hyperproliferation and alignment of Schwann cells into the Bands of Bungner. Infiltrating macrophages facilitate repair by cleaning up axonal and myelin debris. These non-neuronal responses are
essential to successful nerve regeneration. (This figure has been reproduced freely under a Creative
Commons Attribution license. © 2014 Arslantunali et al. Originally published by Dove Medical Press Limited
DOI: https://doi.org/10.2147/MDER.S59124)
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Chondroitin Sulfate Proteoglycans
Proteoglycans are complex molecules featuring a glycosylated core protein and one of
three types of carbohydrate side chains (chondroitin, heparan or keratin sulfates).25 Proteoglycans
are found in the ECM where they often form large complexes with other proteoglycans and hyaluronan. Proteoglycans were initially believed to be "filler" in the ECM following their isolation in
the 1890s but have since been shown to have important roles in cell migration and disease progression. In nerve ECM, proteoglycans play important roles in axonal guidance during development and following injury.26 Individual functions of proteoglycans can be attributed to either the
protein core or attached glycosaminoglycan (GAG) side chains.
Chondroitin sulfate proteoglycans (CSPGs) are the most well characterized of the proteoglycans for their inhibition of axon outgrowth following injury, especially in the CNS where
CSPGs are studied as a physical barrier to axon regeneration as part of the glial scar. The role
of CSPGs in the PNS is far less studied even though it is known that CSPG expression by endothelial cells and Schwann cells increases following PNI.26 CSPGs in the PNS interact with outgrowing neurites via receptors on the neuron cell body and growth cone. 25 Figure 1-3 illustrates
CSPG structure and function following PNI.
In the PNI environment, CPSGs are primarily distributed in the Schwann cell endoneurium
and surrounding newly formed Bands of Bungner.26 Because of their ability to inhibit axon growth,
CSPGs may help prevent aberrant growth into the extraperineurial space that could lead to neuroma formation. This would mimic nervous system development where CSPGs function as necessary guidance cues and are expressed temporally and spatially to guide neurons to appropriate
targets by inhibiting them from entering inappropriate areas. 27, 28 In this thesis we will present
results demonstrating the potential of CSPGs as a unique cue for PNI regeneration and not a
molecule to be avoided.
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A

B

Figure 1-3. Chondroitin sulfate proteoglycans structure and function
Chondroitin sulfate proteoglycan (CSPG) structure (A) and function following peripheral nerve injury. Glycosaminoglycan (GAG) side chains are the inhibitory component of CSPGs and the
GAG, Chondroitin sulfate A (CSA), was chosen as representative of injured nerve extracellular
matrix in this study. (B) Intracellular signaling mechanism triggered by CSPGs. Binding of CSPG
receptors present in axons initiates growth cone inhibition. RhoA activation eventually leads to
actin de-polymerization and growth cone retraction.
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Problem Statement: Current Treatments are Insufficient to Repair Large Nerve Gaps
Traditional treatments for PNI, including coaptation, autografting, and allografting are insufficient to achieve full functional recovery in large gaps (>3 cm in humans). Therefore, several
research groups have focused on neural tissue engineering to replace grafting. The most popular
tissue engineered strategies involve synthetic nerve guide conduits (NGCs), which are hollow
tube devices designed to hold the two nerve ends in close proximity.29 Unfortunately, NGCs have
been unable to match the success of autografts in vivo. In this section, we discuss the drawbacks
of current treatments and propose improvements to the current NGC model. We hypothesize that
many neural tissue engineered strategies have failed because of a lack of study of the complete
regenerative environment before going in vivo. Figure 1-4 summarizes currently available PNI
treatment options based on gap size.

Figure 1-4. PNI repair options by size and availability
As PNI gap size increases, the availability (pink) and utilization (blue) of different treatment options
diminishes. A critical need exists to develop nerve guide conduits that can treat large nerve gaps in
the clinic. (This figure was originally published in the Analysis of the Peripheral Nerve Repair Market in the
United States, 2012 by Magellan Medical Technology Consultants, Inc. and was reproduced freely as part
of the public domain. Original file provided by the author Kurt Brattain).
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Grafting
Coaptation, is defined as the joining or reuniting of two surfaces, in this case the two nerve
stumps following nerve transection. This direct suturing of epineurial structures is the preferred
surgical treatment because it allows for the gross lining up or matching of fascicles and blood
vessels which produces the best functional outcomes.7 When coaptation of the two nerve ends
would result in destructive tension on the tissues, an autologous nerve graft is the favored treatment option. Autografting takes whole or partial donor nerve tissue from elsewhere in the patient's
body to fill the defect site. A single graft is designed to join two nerve ends with a segment of
donor nerve of similar diameter. Gaps in large diameter nerves may require cable grafts, where
multiple fascicular sections of smaller diameter nerves are used to approximate the diameter of
the injured one.12 However, each nerve can contain between 1-100 fascicles each with a diameter
ranging from 0.5-3.5 mm depending on nerve size and location within the body.30 This diversity
of peripheral nerves poses a significant challenge to treatment. Donor nerve is typically harvested
from dispensable sensory nerves, especially the sural nerve made up of collateral branches of
the tibial and common fibular nerve in the distal part of the leg.
All peripheral axons have the potential to regenerate following injury at rates of 2-5
mm/day.31, 32 This rate should translate into bridging a critical gap injury (3 cm) in a matter of days;
however, reinnervation of target tissues can actually take months, which delays functional recovery and leads to muscular atrophy.17 As the nerve defect size increases, functional recovery diminishes. Singh et al.33 performed a comprehensive analysis of 187 patients with complete transection of upper limb peripheral nerves treated with sural nerve autografts. Patients' motor and
sensory recovery was analyzed 18 months after surgery. Outcomes of this study are summarized
in Table 1-2. The percentage of patients achieving ‘good’ motor and sensory recovery (defined
by the British Medical Research Council) diminished with increasing gap size.
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Table 1-2. Peripheral nerve autograft functional outcomes in a clinical trial
The percentage of patients with full motor and sensory recovery following an upper limb injury treated
with a sural nerve autograft diminishes with increasing injury size. n = 187 patients; 18 month follow
up. Data from Singh et al. 1992.

Despite these discouraging outcomes for large peripheral nerve transections, autografting
has remained the "gold standard" treatment for PNI since the 1960s.34 Furthermore, autografting
is associated with a number of other drawbacks including multiple surgeries, donor site morbidity,
size mismatch, and limited tissue availability.35, 36 For patients with extensive nerve injuries and
inadequate autologous donor tissue available, human cadaver nerve allografts have been used.
However, allografting with donor tissue, typically from a cadaver, faces a different set of challenges including immune rejection and disease transfer.4 Therefore, allograft recipients typically
require several years of immunosuppressive therapy. These issues demand an alternative treatment option.
Neural Tissue Engineering
Tissue engineering utilizes biomaterials, cells, and growth factors (GFs), alone or in combination, to restore, maintain or improve tissue function. The traditional definition of tissue engineering involved isolating healthy cells from a patient, expanding them in vitro, seeding the cells
onto a biodegradable scaffold (the NGC in nerves), implanting it into the patient, and allowing the
body to eventually replace the scaffold with newly grown tissue.37 Several NGCs have reached
clinical trials and the market (FDA has approved 11 new devices in the past 20 years). Current
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clinically approved NGCs are made from a variety of materials including: type I collagen, polyglycolic acid (PGA), poly (DL-lactic-co-caprolactone) (PLCL), polyvinyl alcohol (PVA) hydrogel, porcine small intestinal submucosa (SIS) or a combination of these.38 Devices range in length from
2.5 to 6.35 cm and have degradation rates ranging from 4 months to 4 years (some devices are
not bioresorbable). These devices have shown clinical outcomes comparable to autografts but
only in small defect (<3cm), small diameter digital nerves. Unfortunately, these devices are all
structurally similar to what was first introduced in the 1980s, hollow tubes lacking any internal
structure that mimics native nerve tissue39 and therefore they are not successful for treating larger
injuries.
Neural tissue engineers have begun exploring modifications to the basic NGC to improve
regeneration. Popular modifications include growth factor delivery, cell delivery (e.g. Schwann
cells or stem cells), changes to material properties (e.g. porosity, stiffness, conductivity, and degradation) and material size/shape (e.g. micro- or nano-scale topography, gels, fibers, or patterns).
Popular NGC modifications are illustrated in Figure 1-5.39

Figure 1-5. Neural tissue engineering strategies to improve NGCs
Modifications to the basic, hollow nerve guide conduit currently being explored by tissue engineers. (This figure has been reproduced with permission from Neurosurgical Focus and the Journal
of Neurosurgery Publishing Group. DOI: 10.3171/FOC.2009.26.2.E5)
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A full analysis of these modifications will not be described here, but we recommend several great reviews discussing the current state of NGC technology and comparing each of these
modifications.39-43 In this thesis, we have focused on what we believe to be the most promising
modifications for future success based on previous studies, ease of delivery, and ease of clinical
translation. Our objective is to model intrinsic topographical and adhesive cues, that form during
regeneration in short PNI, with biomaterials. We specifically want to explore these cues in the
context of the acute PNI environment. This environment contains inhibitory CSPGs and inflammatory glial and macrophage responses, often overlooked by tissue engineers in their pursuit to
promote axon outgrowth. Therefore, we explore the effects of a representative inhibitory CSPG,
Chondroitin sulfate A (CSA) on neuron, Schwann cell and macrophage responses, especially
CSA-induced neurite retraction in real time. We isolate porcine spinal cord extracellular matrix
proteins (SCM) and utilize it as a growth permissive substrate. We hypothesize that our matrix is
a more complete ECM mimic than fibronectin or laminin cues alone. We then deliver the CSA and
SCM cues as part of a tissue engineered scaffold. Our scaffold features electrospun hyaluronic
acid (HA) nanofibers providing a topographical cue. Lastly, we explore the effects of the SCM and
HA nanofibers on macrophage and Schwann cell response. We hypothesize that our cues can
accelerate repair programs in the cells. These cells normally must spend time aligning and laying
down matrix. By delivering aligned, ECM-containing fibers to the cells, they might be able to “skip
a step” in the repair process. Some of the motivating studies for our work are highlighted below.
Literature Review and Motivating Work
Topographical Cues
Aligned fibers have a well-established benefit for enhancing neurite outgrowth in the fiber
direction.44, 45 Neurite outgrowth has been studied on a variety of natural and synthetic polymers
including gelatin, chitosan, silk fibroin, poly-lactic-glycolic acid, polyurethane, poly-vinyl alcohol,
poly-caprolactone, and any number of combinations of these polymers.37, 46 Aligned fibers can
also be fabricated using a variety of techniques including electrospinning or self-assembly.47 In
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this thesis, we utilize electrospinning to fabricate nanofibrous scaffolds because it is a simple
fabrication method, which can be adapted to create fibers of different sizes from many different
polymers. We use hyaluronic acid (HA) as our base polymer because it has previously been established as a useful polymer for neural tissue engineering48 but more importantly, HA is easily
modifiable and provides a great vehicle to deliver our adhesive cues (SCM and CSA).
Adhesive Cues
We have already discussed the importance of Schwann cell proliferation and alignment
for physically guiding axon regeneration. However, research suggests that following axonal injury
chemical cues are also released into the injury site.49 These molecules are released by Schwann
cells, endothelial cells, immune cells, and even the injured neurons themselves. Consequently,
axon extension based on chemotactic (or diffusible) cues has been the primary approach for
guiding axon regeneration since the late 19th century.50, 51 Chemotaxis describes chemical-induced cell migration, typically the preferential movement of the cells up a concentration gradient
of soluble chemoattractant molecules.52-54 A family of growth factors (GFs) called neurotrophins
are the most popular molecules being studied for promoting peripheral nerve regeneration.55 Neurotrophins play a critical role in regeneration by promoting neuron survival, regulating Schwann
cell differentiation, and organizing axon myelination.56 Unfortunately, growth factor based therapies for peripheral nerve regeneration face a number of challenges. For example, GFs cannot be
delivered in vivo via conventional methods because of systemic toxicity, slow tissue penetration,
and short biological half-lives (minutes to hours).55, 57 Despite these unresolved issues, the established guidance ability of the neurotrophins, has dictated that chemotaxis be at the forefront of
neural tissue engineering research.58
While the study of chemotaxis has a longer history, other types of axonal guidance may
offer benefits that chemotactic cues cannot provide59, specifically establishing cues that last the
lifetime of an implant. Haptotaxis, first described by Carter in 1965, describes directed cell migration along surface bound cues.60, 61 Laminin and its derivatives, have been extensively studied in
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vitro as haptotactic guidance molecules. Several studies have specifically identified the different
concentration gradient thresholds of different surface bound cues necessary to initiate directed
growth.62 However, very few studies have combined permissive and inhibitory guidance molecules into one scaffold and only one study looked at a gradient of an inhibitory molecule (Slit-2).63
Therefore, our approach is innovative because of the unique combination of SCM (permissive)
and CSA (inhibitory) guidance cues and their immobilization within a scaffold. The study of soluble
chemical cues is more popular but immobilized cues within the fibers are expected to more beneficial in large nerve gaps where they can last the duration of the scaffold.
Decellularized Extracellular Matrix
Processed nerve allografts have also gained recent popularity for treating large PNIs. The
resulting decellularized extracellular matrix (ECM) has distinct advantages over synthetic guides
(e.g. biochemical cues) and offers regeneration below autografts but better than NGCs in a 3-way
comparison.64, 65 One of the challenges to using whole acellular allografts, however, is preserving
the nerve layers and ECM structure. Extensive tissue processing methods, including lyophilization, cold preservation, freeze–thaw cycling, detergent processing, and/or irradiation can lead to
poor mechanical properties and frail grafts.64 Here we still deliver ECM cues, using precipitated
matrix proteins, but we allow the HA nanofibers to provide the structural component. Nanofibers
are a good mimic of native ECM size and shape.
Residual CSPGs also present a potential source of inhibition in decellularized allografts.
Groups have found success pre-treating their grafts with bacterial enzyme, Chondroitinase
ABC.66, 67 Most clinical and experimental studies have used ChABC to degrade and inactivate the
entire family of CSPGs within the grafts. Unfortunately, this treatment negates any potential benefits of the CSPG cues. It has been suggested that selective de-inhibition of nerve grafts would
be more beneficial to using them in PNI treatment.68 However, there are no known Chondroitinases that selectively degrade different types of CS chains. CSPGs have the ability to upregulate receptors in advancing growth cones enabling them to bind strongly to the surrounding
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ECM molecules. In the designs proposed here we introduce chondroitin sulfate in a controlled
way so that the cells can benefit from both the CS cues and the ECM.
Schwann-cell Inspired Designs
Another obvious issue with processed allografts is their lack of cells, especially Schwann
cells, and the regenerative cues provided by them. Therefore, many research groups have focused on re-seeding decellularized donor tissue with the patient’s Schwann cells prior to implantation.69, 70 Many groups have worked on pre-seeding traditional tissue engineered scaffolds with
Schwann cells or stem cells, allowing them time to form the Bands of Bungner, prior to implantation. Unfortunately, cell-based therapies, are time consuming, costly, and will be more rigorously
evaluated by the FDA, making clinical translation difficult. Several approaches have been established methods to recreate the bands of Bungner following PNI.
Kofron et al. 2010 and Lopez-Fagundo et al. 2013 both used relief replicas of actual cultured Schwann cells to create microwells and 3D micropillars in the size and shape of these cell
structures. Unfortunately, neither of these studies had significantly improved neurite outgrowth
based on structure size or shape, it was only the presence of a topographical cue, as opposed to
a flat surface, that improved neurite behavior. Furthermore, these approaches required several
complicated fabrication steps and featured non-biologically relevant materials (e.g. PDMS).71, 72
In a study by Georgiou et al. the group designed engineered neural tissue or "ENTs" comprised entirely from aligned Schwann cells.73 While support cells are absolutely critical to the success of an implanted device finding an appropriate delivery system to keep the cells alive is very
difficult to achieve, maintain, and translate.74 Pre-seeding tissue engineered scaffolds with cells
prior to implantation, even if they are autologous cells, will face many challenges to reaching
clinical translation. It is anticipated that the best chance to promote regeneration, and reach patients, is to develop an artificial scaffold that mimics these crucial cellular structures.
The Bands of Bungner have a striated appearance, due to not only the presence of elongated Schwann cells but connective tissue bundles.60 Here we use electrospun nanofibers to
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mimic this natural striated appearance as opposed to the smoothness of these other "bio-inspired"
designs. The primary goal of this thesis is to control the phenotype and behavior of three key cell
types in the peripheral nerve injury environment using naturally derived biomaterials cues to mimic
the physical and adhesive guidance during normal axon regeneration.
Modulating Non-Neuronal Cell Phenotypes
Following PNI, Schwann cells undergo a process sometimes referred to as “dedifferentiation,” assuming a phenotype similar to embryonic development (Figure 1-6A). Macrophages
can also assume distinct phenotypes with different biological activities (Figure 1-6B). Macrophage phenotype exists on a spectrum, but subpopulations of macrophages are broadly classified
into two major groups: "classically activated" macrophages (M1) and alternatively active macrophages (M2). M1 macrophages arise immediately following PNI and have been shown in vitro to
be neurotoxic, releasing pro-inflammatory cytokines. Conversely, M2 macrophages have reduced
production of these cytokines and release factors that promote tissue repair and wound healing.
M2 macrophages have been shown to be neuroprotective and to promote long distance axon
growth even in the presence of inhibitory CSPGs.75
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B

Figure 1-6. Macrophage and Schwann cell phenotypes
Following injury support cells in the microenvironment undergo phenotypical changes. (A) Macrophages can assume classical (M1) or alternative activation (M2). (B) Schwann cells undergo a
“dedifferentiation” process where they assume a phenotype similar to immature cells.
(Part B has been freely adapted from © 2008 Salzer Rockefeller University Press under a Creative
Commons Attribution license. DOI: 10.1083/jcb.200804136)

In recent years, many different tissues engineered systems have emerged to treat large
nerve gaps. These strategies are routinely evaluated for their effects on neurons but not for their
influence on macrophage and Schwann cell phenotype. Following nerve injury, activated macrophages can induce axon retraction. Therefore, approaches aimed at depleting the injury site of
macrophages with anti-inflammatory drugs, such as clodronate and minocycline, have garnered
attenion. An in vitro time lapse video study by Horn et al. concluded that the direct cell-cell contact
of macrophages and neurons initiated axon retraction 100% of the time. However, axon retraction
in response to the macrophages diminished when neurons were cultured on a growth-promoting
laminin substrate. However, the authors did not comment on whether the substrate was affecting
the intrinsic growth capacity of the neuron, or altering the activation state of the macrophages, or
both. In this study, we offer some additional insight by testing the effects of a growth permissive
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substrate, the porcine SCM, specifically on macrophage activation sate. Lastly, Horn et al. reported that only macrophages previously activated to M1, with interferon-y or lipopolysaccharide
(LPS), induced significant axon retraction. This result supports the growing theory that macrophage activation state, and not their presence, is critical when considering nerve regeneration.
Macrophage activation is gaining great popularity for improving outcomes in the regeneration of many tissue types include cardiac, dermal, muscle, bone and neural.76 Most studies,
however, focus on shifting the macrophage phenotype towards M2 using established immunomodulatory cytokines such as IL-4, IL-13, M-CSF or exploratory drugs and compounds. Using
biomaterials to control macrophage activation, however, eliminates the challenges of delivering
these molecules in a clinical setting. Some of the groups who have recently begun testing biomaterials for their effects on macrophage activation are highlighted below.
In a 2013 study, Franz et al created “artificial ECM” (aECM) featuring collagen type I and
highly sulfated HA, a type of GAG. The group found that their matrix possessed immunomodulating properties and dampened inflammatory activity of M1-polarized macrophages. The group suggested that their aECM is a promising coating for other biomaterial implants to modulate the healing response.77 These results were very exciting for us because collagen and sulfated-GAGs are
two primary constituents of our SCM. Furthermore, we test it as an adhesive coating on TCP and
the HA fibers. Franz’s study indicated our potential for success.
Nanotopography can also affect macrophage activation which occurs most likely through
the manipulation of cell shape and orientation.78 Bartneck et al. found that 2D and 3D electrospun
PLGA scaffolds conjugated with RGD (fibronectin derived peptide sequence) reduced macrophage inflammatory responses and directed cells towards M2.79 Potas et al. covalently linked IL10 (an M2 stimulating cytokine) to electrospun PCL scaffolds and the scaffolds were wrapped
around intact rat sciatic nerves. The group found significantly increased expression of M2 macrophages at the scaffold and in the surrounding tissue evidenced by Arginase 1 and CD206 staining.
IL-10 remained immobilized and bioactive for up to 120 days in vivo. The group concluded that
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biofunctionalized nanofibers are useful for manipulating the peripheral nerve cellular environment
and that these types of materials should be adapted for more therapeutic strategies.80 We agree
with these conclusions and aim to utilize topographical (aligned HA fibers) and adhesive biochemical cues (SCM and CSA) in our own scaffolds for directing PNI regeneration.
Biomaterials approaches to altering Schwann cell phenotype have garnered less interest
than macrophage studies. However, a few groups having studied the effects of topography81, 82,
stiffness83, soluble growth factors (e.g. neuregulin)84, and ECM (e.g. collagen and laminin),85 for
regulating Schwann cell function, especially actin cytoskeletal dynamics, migration, myelination.
There are also many groups working on differentiating stem cells from a variety of sources (e.g.
human dental pulp, adipose tissue, and umbilical cord) towards a Schwann cell phenotype for
treating PNI.86, 87 These cells are often combined with a biomaterial scaffold. But very few studies
are looking at the phenotypical transition, from dedifferentiated/immature to mature, in the
Schwann cells as we do here. Cellular plasticity and a spectrum of activation has been demonstrated with macrophages. Schwann cell phenotype can also exist on a spectrum. We believe
these two non-neuronal cell types undergo paralleled changes following injury that can be studied,
modeled, and influenced similarly with biomaterials.
All of the studies reviewed here motivated the work in this thesis. However, these approaches to PNI repair have never previously come together into a single body of work. Our collective studies offer improved insight into the endogenous potential of the injured peripheral nerve
and offer ways to incorporate intrinsic repair cues into a biomaterial system for treating large gaps.
Summary
In a recent review in Experimental Neurology, Webber and Zochodne argued that improving regenerative success [in peripheral nerves] requires "...models that prominently display the
problem at hand and a means to locally influence the regenerative milieu."88 Many current peripheral nerve repair strategies focus on delivering positive, growth promoting cues (e.g. extracellular

23

matrix, ECM) while eliminating negative, growth inhibiting cues (e.g. chondroitin sulfate proteoglycans, CSPGs) at the injury site. We hypothesized that recapitulating the positive and negative
cues of the peripheral nerve injury microenvironment would improve regeneration. Moreover,
other groups often fail to test the effects of their cues on cell types other than the neurons. We
aim to provide appropriate substrates to facilitate Schwann cell and macrophage responses as
well as axonal outgrowth.
In Chapter 2, we tested the effects of a characteristic CSPG, Chondroitin Sulfate A (CSA)
on neurite dynamics of dissociated chick embryo dorsal root ganglion (DRG) neurons using time
lapse video microscopy. DRG growth was recorded on different adhesive substrates, including a
novel, porcine-derived spinal cord matrix (SCM). The SCM significantly increased frequency of
neurite extension coordinated by a significant reduction in the neurites’ time spent stalled. The
SCM also mitigated inhibitory effects of CSA, producing longer neurites than the controls without
CSA treatment. We also quantified neurite extension and retraction rates. Next we aimed to elucidate receptors involved in mediating the observed neurite behavior. We hypothesized that CSA
mediates the upregulation of cell-surface binding receptors in the neurons and tested this using
flow cytometry with fluorescently tagged antibodies for the neurons' surface molecules. Our results showed a significant increase in Syndecan-3 receptor expression in neurons treated with
CSA. Syndecans would most likely bind to the sulfated glycosaminoglycans measured in our
SCM. Together these results suggest that CSA plays an important role in priming cells to bind
newly synthesized ECM during repair and our isolated SCM is a good mimic of native ECM.
In Chapter 3, we modify our CSA and SCM cues to be presented as part of a biomaterial
scaffold. To immobilize the CSA, we methacrylate it to CSMA using an established protocol for
creating methacrylated hyaluronic acid (MeHA). CSMA, SCM, and MeHA polymers were electrospun into scaffolds to deliver these adhesive molecules along with a topographical cue (aligned
nanofibers). The ability of these scaffolds to promote neuron outgrowth was again tested with
chick embryo DRGs. Our results showed significantly increased neurite outgrowth on electrospun
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hyaluronic acid fibers with SCM and low levels of CSA. Higher incorporation of CSA maintained
its inhibitory properties.
In Chapter 4, we evaluate the ability of our biomaterials cues from Chapters 2 and 3 to
modulate the phenotypes of macrophages and Schwann cells (SCs). Specifically, we explored
the effects of the CSA (soluble, chemical cue), SCM (adhesive cue), and aligned HA nanofibers
(topographical cue). We hypothesized that one or more of our biomaterials cues would accelerate
the macrophages return to a resting state, following classical activation (M1) with lipopolysaccharide (LPS) and/or direct the cells towards an alternative activation (M2) state. Analogously, we
hypothesized our cues would accelerate the SCs transition to a mature/pro-myelinating state,
following treatment with LPS, used here to mimic immaturity/injury. Cell phenotypes were functionally assessed 12, 24, and 48 hours following LPS stimulation. Quantified reverse transcription
polymerase chain reaction (qRT-PCR), immunofluorescence (IF), and sandwich-ELISA based
antibody arrays were used to measure changes in mRNA expression, morphology, and cytokine
release, respectively.
Our results showed that the SCM and HA nanofibers suppressed the effects of LPS on
the macrophages by reducing inducible nitric oxide synthase gene expression. The HA fibers also
prevented LPS-induced morphological changes. Release of IL-1a, an M1 cytokine, was also reduced from cells cultured with these cues. Similarly, the SCM and HA fibers significantly influenced Schwann cell phenotype. Mature gene markers, Oct6 and Krox2, were significantly upregulated while immature markers such as GFAP were significantly downregulated. SCs on the fibers
assumed a mature, bipolar morphology, significantly elongating in the fiber direction. Furthermore,
these changes were observed in as little as 24 hours, much faster than previous studies.
In Chapter 5, we present the overall discussion and conclusions of this work and proposed
future directions. We developed a method for measuring receptor expression in the neurons
(Chapter 2) and we suggest expanding this flow cytometry effort to include other syndecans, other
receptors (e.g. integrins), neurons cultured with our other biomaterials cues, and the other cell
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types (macrophages and SCs). Based on the improved neurite outgrowth observed on our CSMA
and MeHA, and SCM and MeHA, scaffolds (Chapter 3) we predict that coupling these cues will
have synergistic effects on neurite outgrowth. We are especially interested in delivering the cues
as opposing linear gradients. We ultimately aim to create a single, scaffold system that could be
implanted inside existing NGCs during normal PNI surgeries and we discuss some methods for
moving our biomaterials in vivo. In the future, we propose to test our biomaterials with co-cultures
of the DRG neurons and non-neuronal cells (macrophages and SCs) based on the significant
changes in these cells’ morphology and cytokine release (Chapter 4).
Overall, we believe that we have provided a collection of approaches to understanding
and utilizing the inherent regenerative potential of injured peripheral nerves. We believe the insight provided here can serve the design of other tissue engineered systems for large peripheral
nerve gaps or be adapted to study the neurons, immune cells, and glia of the CNS. Moreover, we
hope the specific biomaterials explored here will find widespread application in the nervous system.
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CHAPTER 2: POSITIVE AND NEGATIVE CUES FOR MODULATING NEURITE DYNAMICS AND RECEPTOR EXPRESSION
Introduction
Chondroitin sulfate proteoglycans (CSPGs) are extracellular matrix (ECM) molecules of
interest that may be overlooked during peripheral nerve repair. CSPGs are well-known for their
inhibitory role in the central nervous system following spinal cord injury89, but CSPGs are also
deposited by endothelial, inflammatory, and Schwann cells following peripheral nerve injury (PNI).
Despite increased CSPGs in the PNI microenvironment, only a few groups have explored the
effect of CSPGs on peripheral neurons.20, 26, 90 Rather, most neural tissue engineering research
focuses on delivering only growth promoting factors to encourage neurite outgrowth. We hypothesize that recapitulating the injury microenvironment with both positive (growth permissive) and
negative (growth inhibitory) cues can better promote nerve regeneration.
In this study, we investigated the ability of materials-based cues to modulate neurite behavior and receptor expression in peripheral neurons. Our first objective was to quantify the effects of a characteristic CSPG, Chondroitin Sulfate A (CSA), on neurite extension and retraction
using time lapse video microscopy. Secondly, we investigated the ability of a novel biomaterial,
derived from porcine spinal cord matrix (SCM), to improve neurite outgrowth in the presence of
the inhibitory CSA. Lastly, we measured the ability of CSA to induce Syndecan-3 receptor expression in peripheral neurons using flow cytometry.
Axons in the PNI environment face obstacles to regeneration including inflammatory cells,
inhibitory chemical cues, and physical barriers.91 We have hypothesized that these obstacles induce axon retraction events leading to regeneration failure. Selective axon retraction, or pruning,
is a normal part of healthy tissue development17, 19, however, the role of axon retraction following
PNI is less understood and less studied. Few studies have used live cell imaging techniques to
examine neurite retraction behaviors. Even fewer studies have examined neurite retraction in
response to a negative cue, such as CSPGs. Of over thirty studies reviewed that reported using
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time lapse imaging to capture neurite retraction in response to cues such as force induction 92, 93,
topographical barriers72, 94, substrate mechanics95, 96, chemical cues50, 97, or other cells98, only four
quantified their observations. Therefore, the first objective in this study was to quantify the effects
of soluble CSA (mimicking CSPGs liberated from healthy ECM following injury) on neurite extension and retraction in real-time.
It has previously been demonstrated that CSPG exposure can lead to increased membrane density of beta-1 integrins in peripheral neurons.99 Furthermore, the effects of blocking
antibodies against beta-1 integrins were dependent on the in vitro substratum, with especially
permissive substrates able to overcome the effects of the block.100 In addition to upregulating
integrins, we hypothesized that CSA can also induce the upregulation of another class of surface
receptors called syndecans. Syndecans perform diverse functions including participation in cellmatrix and cell-cell adhesion, migration, and proliferation.101, 102 Syndecans can also bind a wide
variety of ECM molecules and growth factors.103 Syndecan-3 was the focus in this study because
it is the most abundant syndecan in the nervous system.104 Though typically studied as inhibitors
to regeneration, we predict CSPGs can prime neurons for growth by inducing the upregulation of
Syndecan-3.
Laminin has a long-established ability to promote neurite formation and extension105, 106
and remains a popular adhesive substrate in neural tissue engineering, especially because it
binds to integrins.107 However, we hypothesized that our SCM would provide a more diverse and
physiologically relevant substrate resulting in better neurite growth. Therefore, we tested SCM as
an adhesive substrate for culturing neurons in the presence of soluble CSA.
The SCM significantly increased frequency of neurite extension coordinated by a significant reduction in the neurites’ time spent stalled/unmoving. Furthermore, neurons grown on the
SCM, even in the presence of CSA, had longer neurites than control substrates without CSA. Our
results also showed a significant increase in syndecan-3 expression in DRG neurons treated with
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CSA, compared to basal expression in untreated neurons. We expect that CSA-induced upregulation of syndecan-3, and the heterogeneous composition of the SCM, (especially presence of
sulfated glycosaminoglycans) modulates neurite behavior via Syndecan-matrix binding.
Experimental
Materials
Reagents used for the spinal cord matrix (SCM) isolation include fresh-frozen porcine spinal cords (ECM Science), sodium acetate (Sigma), Ethylenediaminetetraacetic acid (EDTA; Calbiochem), acetic acid (EMD Millipore), and sodium chloride (Fisher BioReagents). Colorimetric
assay reagents include Direct Red 80 (Alfa Aesar), and 1,9-dimethyl-methylene blue (DMMB),
type I collagen from calfskin, and papain buffer all from Sigma. Serum free cell culture media
(SFM) was composed of DMEM/Ham's F12 (GE Healthcare Life Sciences), 2mM L-glutamine
(GE Healthcare Life Sciences), 50 U/mL Penicillin-Streptomycin (Sigma), 0.6% B-27 nutrient supplement (Gibco Life Technologies) and 50 ng/mL nerve growth factor (NGF; R&D Systems). Other
culture materials include laminin (Calbiochem) and chondroitin sulfate A from bovine trachea
(CSA; Sigma). Neurons were harvested from chick embryos; eggs purchased from Charles River
(Roanoke, IL). Immunocytochemistry materials include primary anti-neurofilament 200 (Sigma),
secondary AlexaFluor488 goat anti-mouse IgG (Invitrogen), 4',6-diamidino-2-phenylindole (DAPI;
Fisher), paraformaldehyde (PF; Acros Organics), Triton-X (MP Biomedicals), bovine serum albumin (BSA; Fisher BioReagents), and goat serum (Sigma). Flow cytometry materials include Accutase (MP Biomedicals), primary anti-Syndecan-3 (Santa Cruz Biotechnology), secondary goat
anti-rabbit IgG-FITC (Santa Cruz Biotechnology), primary anti-neurofilament 200 (Chemicon) and
secondary AlexaFluor594 goat anti-rabbit IgG (Invitrogen).
Isolation and Characterization of Spinal Cord Matrix Proteins
Our adhesive substrate was derived by isolating protein components from frozen, closed
herd porcine spinal cords. The cords were disinfected with 1% sodium hypochlorite, washed in
cold phosphate buffered saline (PBS) to remove unbound material, and then immersed in PBS
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containing 0.5M sodium acetate and 0.1M EDTA to remove exogenous protein. Cords were rinsed
three times with PBS, blended into small pieces, and digested in 0.02M acetic acid for 4 days.
Matrix proteins were then salt precipitated with increasing concentrations of sodium chloride (up
to 2M), dialyzed against deionized water, and lyophilized for the final product.
The concentrations of sulfated glycosaminoglycans (sGAG) and collagen in the spinal
cord matrix (SCM) were measured using absorbance spectrophotometry. sGAG content was
quantified by DMMB binding according to a previously published protocol108 while collagen content was measured using an adapted Sirius red-based colorimetric assay.109 Lyophilized SCM
specimens (n=8; dry weight=25 mg) were digested in either papain buffer or 0.1M acetic acid prior
to measuring sGAG and collagen, respectively. CSA (0.2-2 μg/well) and collagen I (20-200
μg/well) were used to create standard curves for the DMMB and Sirius Red assays, respectively.
Final values are reported as μg of sGAG, or collagen, per mg of dry weight of SCM.
Dissolution of the dried matrix proteins in 0.1M acetic acid was facilitated using an orbital
shaker for 2 days. The solution was centrifuged at 3000 rpm for 10 minutes to pellet any insolubles, and the supernatant was collected and used as the experimental substrate for the following
cell experiments.
Cell Culture
Chick embryo dorsal root ganglia (DRG; E9-11) were harvested, trypsinized, and mechanically dissociated according to a previously described protocol.110 Dissociated neurons were
plated (6000 cells/cm2) in a 24-well tissue culture plastic plate coated with either spinal cord matrix
(SCM, experimental condition), laminin (LAM) or left uncoated (denoted TCP). Wells were coated
via adsorption by incubating in either the SCM or LAM solutions (5 μg/cm2) for 4 hours and rinsing
3x with PBS (laminin manufacturer’s protocol). Neurons were cultured for 2 days in serum free
media (SFM) either with or without 10 μg/mL Chondroitin Sulfate A (CSA).
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Microscopy and Image Analysis
Time Lapse Video
Dynamics of extending neurites were recorded using a Nikon Eclipse inverted microscope
fitted with an incubation chamber maintained at 37C, 5% CO2, and 90% humidity. Bright field
images were captured every 10 minutes, for 12 hours, beginning 24 hours after seeding (to allow
for sufficient cell attachment). The following parameters were measured from the video recordings: average neurite extension and retraction rates (μm/min) and extension, retraction and stalled
time as a percentage of total neurite movements. Neurite length was measured as a straight line
from the center of the neuron cell body to the neurite tip in every frame of the time lapse videos.
The change in neurite length between frames was used to determine if the neurite was actively
extending, retracting, or remaining unchanged/stalled for any given 10 minute interval. Changes
in neurite length less than ± 5μm were considered negligible. The use of ±5 µm as the cut-off for
eligibility of neurite extension or retraction was due to limitations in measurement and consistency.
The three types of neurite movement (extension, retraction, or stalled) were then reported as
percentages of a given neurite's total movements. For every change in neurite length, an extension or retraction rate was determined by dividing the respective change in neurite length by the
time interval between frames and the average extension and average retraction rates were determined across all cells.
Figure 2-1 shows examples of the neurite length measurement technique and the types
of neurite movements analyzed from the time lapse videos. Only neurites reaching a total length
of greater than two times the cell body diameter were included. Neurites that contacted another
neurite or another cell body, or that left the field of view, were excluded. For highly branched
neurites, only the branch reaching the longest maximum length was traced, even if that branch
did not remain the longest throughout the entire video (supplemental video 1).
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Figure 2-1. Types of neurite movements and measurement technique
Still images from a representative time lapse video illustrate the three types of neurite movements
analyzed – retraction, extension, and stalled (change in length <± 5 μm). Neurite length was
measured as a straight line from the center of the cell body to the neurite tip (black arrow) in each
frame of the time lapse videos. Change in length between each frame was used to determine if
the neurite was extending, retracting, or stalled/remaining unchanged. Time shown in hh:mm.
(© IOP Publishing. Reproduced with permission. All rights reserved. https://doi.org/10.1088/1748605X/aa61d1)

Immunofluorescence
After 48 hours of total culture time, cells were fixed (4% PF), blocked (1% goat serum),
and stained with anti-neurofilament and DAPI to visual neurites and cell nuclei, respectively. Final
neurite lengths were measured from fluorescent micrographs as described for measuring neurite
length in the videos. 5 random positions were imaged for each replicate (n=3) of each condition.
The experiment was repeated 4 times for a total of 60 images per condition. Images were captured using NIS Elements software (Nikon) and analyzed using ImageJ. The seeding density
(6000 cells/cm2) and total culture time (48 hours) were specifically selected because, when grown
for longer periods, neurites began to contact one another and formed networks that made tracing
individual neurites impossible. Finally, DRG neurons cultured for 48 hours, with or without CSA,
were also stained with anti-Syndecan-3 to visually confirm receptor expression prior to quantification using flow cytometry.
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Flow Cytometry
The ability of CSA to induce the upregulation of Syndecan-3 receptors was quantified using flow cytometry as previously described for measuring opioid receptor expression in murine
DRG neurons with slight modifications.111, 112 Chick embryo DRG neurons were harvested, dissociated, and seeded on TCP in SFM containing 10 μg/mL CSA as described above for the video
experiments. After 48 hours, neurons were detached from the plate using Accutase and spun
down at 2000 rpm for 3 minutes. The cell suspension was washed in PBS containing 1% BSA
and 0.5% Triton-X (wash solution), fixed in 4% PF, blocked in 1% goat serum, and incubated in
an amino-terminal (1-300) anti-Syndecan-3 receptor antibody for 30 minutes on ice (1 μg/500 mL
wash solution). After a further wash and incubation for 30 minutes in the secondary antibody (goat
anti-rabbit IgG-FITC, 1:100), a minimum of 20,000 neurons per sample were analyzed on an
Attune Acoustic Focusing Cytometer (Blue/Violet System) using Attune Cytometric Software v2.1
for acquisition (Applied Biosystems).
Gating for the neuronal population was conducted using the following steps in each experiment. First, the population of interest was defined as region 1 (R1) by size (forward scatter,
FSC-H) and granularity (side scatter, SSC-H). To confirm this gated population contained neurons, while excluding cellular debris and dying cells, samples were stained with primary neurofilament (1 μg/mL) and secondary antibodies for 30 minutes each on ice. DAPI staining (400 ng/mL;
5 minutes) was used to identify cellular debris, dead, and dying cells. The population of interest
was thus confirmed to be neurons by staining positively for neurofilament and negatively for DAPI.
Figure 2-2 shows example density plots of the gating steps.
Neurons cultured in SFM without CSA treatment were used to determine basal expression
levels of Syndecan-3. Treated and untreated cells without any antibody staining were used to
control for background/autofluorescence. Nonspecific fluorescence, measured from cells stained
with just the secondary antibody, was subtracted and the mean fluorescence intensity (MFI) was
obtained for each sample.

33

Figure 2-2. Flow cytometry gating steps
Flow cytometry was used to analyze Syndecan-3 expression in primary chick embryo DRG neurons detected by fluorescent antibodies to the receptor antigen. Samples were gated first by their
characteristic forward (FSC) and side (SSC) scatter profiles (A). Cells were gated as region 1
(R1), eliminating very small events such as cellular debris. For this representative example (total
event count: 82,967), region 1 contained 30% of the events (24,893). DAPI was used as the
live/dead discriminator (B). DAPI negative events represent the fraction of viable cells within R1
(90%; 22,403). Finally, neurons were identified from a plot of neurofilament (NF) fluorescence
against side-scatter (C). The NF positive cells represent the fraction of R1 that is specifically neurons (81%; 20,163). This sequence of gating steps was used for each experiment in order to confirm that a minimum of 20,000 neurons were ultimately analyzed for Syndecan-3 expression.
(© IOP Publishing. Reproduced with permission. All rights reserved. https://doi.org/10.1088/1748605X/aa61d1)

Results
Spinal Cord Matrix Protein Quantification
Average collagen concentration of the SCM was 296.2 ± 25.2 μg collagen/mg dry weight,
while average sulfated glycosaminoglycan concentration was 4.3 ± 0.4 μg sGAG/mg dry weight.
‘Dry weight’ describes the full starting weight of the SCM, however, a small fraction of the SCM
was insoluble. Thus, collagen and sGAG content in our SCM coatings may be higher than reported here. Nevertheless, our results are comparable to a study by Medberry et al. that used
similar assays to measure collagen and sGAG content of decellularized pig spinal cords.113
CSA Treatment and SCM Substrate Influence Neurite Outgrowth Parameters
In this study, we used time lapse video microscopy to record outgrowth parameters of
peripheral neurons. We measured frequency and rate of neurite retraction, which are observed
but not often quantified in the literature, especially in response to a ‘negative’ cue such as CSA.
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Our results showed that neurites spent an average of 17.7  2.8% of their “time” (meaning of the
video frames) retracting for all culture conditions tested (one-way ANOVA; F0.05 (5,138) = 1.42; p =
0.22). CSA had no significant effect on the frequency with which neurites retract. Neurons cultured
on the SCM substrate spent significantly more time extending compared to the laminin and plastic
controls. Moreover, this increased extension on the SCM corresponded to a significant decrease
in the time the neurites spent stalled/unmoving compared to both controls. This trend was maintained for conditions with and without the CSA, although only the latter was statistically significant.
A complete summary of neurite movements for cells grown in each of the six culture conditions is
presented in Figure 2-3A. For each condition, the three types of neurite movement — retraction,
extension, and stalled — add to 100% of total movements. The frequencies of retraction, extension, and stalling occurred independent of whether the cell was in the early or later stages of
culture.
Average neurite extension and retraction rates were also measured from the time lapse
videos. Average extension rates were statistically similar between all six experimental conditions
(one-way ANOVA; F0.05 (5,137) = 1.53; p = 0.19). Average retraction rates on the plastic and laminin,
with or without CSA, were also statistically similar to one another. Interestingly, neurons grown
on the SCM had significantly increased retraction rates compared to the two control substrates
(Figure 2-3B). This result was surprising given that neurons grown on the SCM had the longest
final neurite lengths overall (next section). However, this unexpected outcome reinforces that the
SCM is indeed a permissive substrate for neurite outgrowth in spite of neurite retraction behaviors.
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Figure 2-3. Quantified neurite behavior from the time lapse videos
(A) Average time spent extending, retracting, or stalled as a percentage of the neurites’ total
movements. Neurons on SCM spend significantly more time extending, and significantly less time
stalled, than controls. (B) Average neurite extension and retraction rates. Extension rates are
statistically similar for all conditions. The retraction rate of neurons cultured on the SCM are significantly greater then neurons cultured on TCP-CSA and LAM-CSA. * indicates p<0.05; 4 trials,
3 replicates per condition per trial, n>18 neurites measured per condition.
(© IOP Publishing. Reproduced with permission. All rights reserved. https://doi.org/10.1088/1748605X/aa61d1)

SCM Substrate Promotes Growth in the Presence of CSA
Following the time lapse recordings, the neurons were fixed and stained to analyze final
neurite outgrowth using immunofluorescence microscopy. Example fluorescence micrographs of
neurons grown on laminin (LAM) or spinal cord matrix (SCM) substrates with (+) or without (-)
Chondroitin Sulfate A (CSA) are shown in Figure 2-4A. Final average neurite lengths were quantified from 4 independent experiments, each with 3 replicates of the 6 conditions. Greater than 95
total neurites were measured for each condition. Results, reported as mean ± standard error, are
summarized in Figure 2-4B.
The results revealed significantly reduced growth in the presence of the CSA for neurons
grown on all substrates. This result was not surprising as CSA has previously been demonstrated
as an inhibitor of neurite outgrowth.114, 115 However, neurons grown on the SCM had the longest
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average neurite lengths overall. Neurons grown on the SCM without CSA had significantly longer
neurites than all other conditions. Neurons grown on the SCM with CSA had significantly longer
neurites than the neurons grown on TCP or LAM with CSA. Furthermore, cells cultured on the
SCM with CSA had an average neurite length significantly longer than those cells on TCP without
CSA treatment, suggesting that our matrix substrate promotes neurite growth even in the presence of the soluble inhibitor.

Figure 2-4. Quantified neurite outgrowth from the fluorescence micrographs
(A) Dorsal root ganglion neurons grown on laminin (LAM) or spinal cord matrix (SCM) coated
plastic, treated with (+) or without (-) Chondroitin Sulfate A (CSA) stained with anti-neurofilament
(green) and DAPI (blue) to visualize neurites and cell nuclei, respectively. Scale bars = 50 μm.
(B) Quantification of neurite outgrowth after 48 hours. CSA significantly reduced neurite outgrowth in all conditions. Neurons grown on SCM without CSA were significantly longer than all
other conditions, + p<0.05. Neurons grown on SCM with CSA were significantly longer then all
conditions except LAM-CSA and SCM-CSA, # p<0.05. n>95 neurites measured per condition.
(© IOP Publishing. Reproduced with permission. All rights reserved. https://doi.org/10.1088/1748605X/aa61d1)

Final neurite lengths agreed with the video results for each culture condition. Using the
‘SCM-CSA’ neurons as an example, the video results showed these cells spent an average of
18% of the time retracting at an average rate of 1.55 μm/min, while they spent an average of 35%
of the time extending at an average rate of 1.00 μm/min. Given that total culture time was 48
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hours (2880 minutes), and the remaining 47% of the videos the neurites were stalled (0 μm/min),
the expected final outgrowth would be
μm

μm

μm

((1.00 min × 0.35) − (1.55 min × 0.18) + (0 min × 0.47)) × 2880 mins = 204.5 μm
which is well within the range measured from our micrographs; final average neurite length on the
SCM-CSA was 213.1 ± 14.6 μm.
Given that average neurite extension rates were similar among all groups, it is more likely
that the increased extension frequency, and reduced neurite stalling, on the SCM led to the longest overall neurite outgrowth despite the increased retraction rates on the SCM. Moreover, these
increased retraction rates may have to do with two different mechanisms of retraction (resorption
vs. fragmentation) on the different substrates (more details in Discussion section).
CSA Treatment Increases Syndecan-3 Receptor Expression
Flow cytometry was used to determine the effect of Chondroitin Sulfate A on Syndecan-3
receptor expression in the DRG neurons. Expression was quantified using the median fluorescence intensity (MFI) normalized to cells that were not exposed to CSA. The results revealed a
21.5 ± 7.6% increase in Syndecan-3 expression for the neurons treated with CSA compared to
the untreated control (p < 0.05; Student’s t-test; n = 6 experiments). We also tested concentration
dependency of the receptor upregulation on neurons using 1 mg/mL CSA. At the higher CSA
concentration, the neurons were unable to be lifted from the dish in order to conduct flow cytometry. However, this observation supports our hypothesis that CSA increases cell-substrate binding. Figure 2-5 contains a representative histogram (2-5A) of receptor expression (relative fluorescence) from the flow analysis as well as summarized MFI results (2-5B).
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Figure 2-5. Syndecan-3 expression in DRG neurons
(A) Syndecan-3 expression increased in fluorescence intensity for CSA-treated neurons compared to the untreated control cells as evidenced by the peak shift. (B) Quantification of flow cytometric analysis reported as median fluorescence intensity (MFI). MFI statistically increased for
CSA-treated cells compared to untreated controls. *p<0.05; Student’s t-test (n=6). (C) and (D) Immunofluorescence micrographs reveal Syndecan-3 expression throughout the cell body, neurite,
and growth cone of untreated (-CSA) and treated (+CSA) cells. Scale bars = 100 μm.
(© IOP Publishing. Reproduced with permission. All rights reserved. https://doi.org/10.1088/1748605X/aa61d1)
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Syndecan-3 immunostaining was also performed on the CSA-treated DRG neurons to
identify localized receptor expression. However, the fluorescence micrographs revealed that
Syndecan-3 expression was present throughout the cell bodies and neurites. Furthermore, expression was clearly present in the control neurons (no CSA) as well as the CSA-treated ones
(Figure 2-5C and 2-5D). However, this result is not surprising given that we know Syndecan-3 is
constitutively expressed in the nervous system and we know from the flow cytometry results that
receptor expression was indeed increased with CSA treatment. Furthermore, previous studies
have suggested that CSA can affect DRG neurons at both the growth cone and the cell soma.116
It is worth noting that neurons in the micrographs were stained (antibody concentrations) and
imaged (exposure times) using the exact same methods and the images have not been modified
in any way.
Discussion
In this study, we have successfully recorded neurite outgrowth dynamics using live cell
imaging. Our results provide previously unreported neurite retraction parameters, particularly in
response to a negative cue (CSA). While published data on neurite retraction rates is inconsistent,
studies have reported comparable neurite extension rates for chick embryo DRG neurons as reported here.50, 117 Other studies have also reported that DRG neuron extension rates are not affected by their growth substrate. We measured significantly increased retraction rates for neurons
grown on the SCM. This result was especially surprising given that these neurites were the longest overall. One possible explanation for this difference could be the mechanism of retraction on
the SCM substrate vs. the controls.
Time lapse videos revealed that most neurites underwent simple retraction, or resorption,
where the axonal cytoplasm is intact and all components (e.g. actin and microtubules) are returned to the cell soma (supplemental video 2). Simple retraction is a controlled process that
requires time for protein depolymerization.118 Neurons on the SCM, however, appeared to undergo fragmented retraction as opposed to simple retraction (supplemental video 3). Fragmented
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retraction occurs when return of all the axonal proteins would not be energy efficient for the cell
and therefore axon shedding occurs.119 Neurite length provides one indicator of whether or not a
neuron will undergo fragmentation, with a threshold for fragmented retraction of approximately
200 μm.120 Because the SCM neurons were the only ones with an average length >200 μm, this
may be one explanation for the faster retraction rates.
Despite the increased retraction rates, neurons grown on the SCM substrate were still the
longest overall. This result may be attributed to these cells spending significantly more time extending than stalled compared to controls and regardless of CSA treatment. Increased extension
and reduced stalling on the SCM may stem from the heterogeneity of the matrix. Laminin, for
example, binds preferentially to integrins. CSPGs are also capable of binding to integrins at the
same sites that would bind laminin.115 We speculate that integrin binding becomes saturated on
substrates such as laminin leading to increased neurite stalling. Our SCM, however, provides
collagen sites for integrin binding as well as GAG binding sites for syndecan receptors, potentially
making it an improved substrate over traditional adhesive cues.
Our study shows, for the first time, significantly increased expression of Syndecan-3 receptors in response to CSA treatment in neurons. This increase in Syndecan-3 receptors could
lead to increased neuron interactions with the growth substrate and therefore increased neurite
extension. The presence of these receptors elucidates one positive role for the chondroitin sulfate
released following PNI. The increase in Syndecan-3 expression measured here was significant
but modest; this result could be explained by the experimental timeline. For example, a study by
Bao et al 2011 used flow cytometry to examine integrin receptor expression following spinal cord
injury and saw the onset of increased expression was at 12 hours.121 Thus syndecan expression
may have peaked and declined by the time we analyzed the cells (48 hours of CSA treatment
was chosen in order to match the total culture period of the microscopy data). Additionally,
syndecans modulate cell-substrate binding, but flow cytometry required lifting the cells from the
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dish. This step may have cleaved or otherwise degraded some receptors before analysis, therefore we were not measuring a maximal level of expression. Nevertheless, our results are appropriate for the cell type being tested and are comparable to previously published reports that have
used flow cytometry to measure receptor expression in other neurons.111, 112
Syndecan receptor trafficking in neurons is not fully understood, so we can only speculate
on the mechanism by which CSA induces Syndecan-3 expression. However, we know that CSA
can lead to increased intracellular calcium in the growth cone115, which plays a role in initiating
many signaling cascades and may include syndecan synthesis. We have also speculated on
mechanisms by which upregulated Syndecan-3 receptors could mediate the improved outgrowth
observed on the SCM. First, we anticipate that upregulated syndecans would bind to the sulfated
GAGs present in the SCM (especially heparan sulfate) allowing extending neurites to maintain
strong adhesion to the substrate without saturating other key binding receptors (e.g. integrins).
This binding would promote more continuous neurite extension with fewer stalling events. Secondly, the CSA-induced syndecans could act as co-receptors for the binding of certain integrin
variants mediating improved focal adhesion formation and migration.122 Additionally, both integrin
and syndecan receptors provide interaction between ECM ligands and the actin cytoskeleton via
their role in intracellular signaling machinery. These pathways may work together to inhibit phosphorylation of Rho which is known to mediate actin and myosin depolymerization leading to neurite contractility.22 Finally, the increased syndecan receptors could work to stimulate neurite outgrowth by sequestering NGF in the media at the cells’ surface.103
Many PNI repair strategies focus on counteracting inhibitory signaling of the CSPGs released at the injury site. Popular approaches to counteracting CSPGs include inhibiting their
downstream signaling pathways with Rho/ROCK inhibitors123,
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or degrading the GAG side

chains with bacterial enzyme Chondroitinase ABC.125, 126 We suggest these treatments of PNI
may be flawed. These drugs would alter the CSA-syndecan response reported here and ultimately
may inhibit the cells ability to bind strongly to ECM during regeneration.
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Despite a few conflicting studies127, 128, the now leading hypothesis for how CSPGs interact, and therefore inhibit, neurite outgrowth is through the GAG side chains rather than the protein
core. Thus, our study utilized chondroitin sulfate A (CSA) as the representative inhibitory component of injured nerve ECM. Chondroitin sulfate is the most abundant of the GAGs in the nervous
system and other studies have used CSA specifically as an inhibitory molecule in the study of
axon behavior.129 We recognize that soluble CSA and immobilized CSA (or CS that is protein
bound, CSPG) can interact with both the neurons and other substrate proteins in different ways.26,
130

Given the flow cytometry results with soluble CSA (increased Syndecan-3), however, we hy-

pothesized that low levels of immobilized CSA would be beneficial for neuron growth. Therefore,
we needed a way to present the CS cue longer term, especially if it was to ultimately be part of
an implantable PNI repair strategy. In the next Chapter, we present a method for immobilizing the
CS cue within the hyaluronic acid nanofibers.
Conclusions
In this study, we have demonstrated that porcine spinal cord matrix (SCM) proteins are an
especially permissive substrate for culturing peripheral neurons and mitigating inhibition of Chondroitin Sulfate A (CSA), using time resolved and quantified extension and retraction data. Additionally, this was the first look at the influence of a CSPG on syndecan receptor expression using
flow cytometry with chick embryo neurons. The objective of this research is not only to identify
positive and negative cues for promoting neuron growth but to ultimately utilize these cues as part
of an implantable tissue engineered device.
Several nerve regeneration strategies aim to degrade or block CSPG effects pharmacologically. CSPGs have previously been explored for regeneration in cartilage131, bone132, and
skin133 but very few studies have explored the potential benefit of incorporating CSPGs into a
tissue engineered scaffold for neural regeneration. We are interested in exploiting positive roles
for CSPGs as part of a tissue engineered PNI repair strategy. Our long-term goal is to fabricate a
biomaterial scaffold featuring ECM and CSPG cues that will provide support for, or even replace,
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the Bands of Bungner and is expected to succeed in larger defects where current treatments fail.
In the next Chapter, we explore combinations of our SCM and CSA cues and incorporation of
these cues into an electrospun nanofibrous scaffold for promoting nerve outgrowth.
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CHAPTER 3: NEURITE OUTGROWTH ON NANOFIBROUS SCAFFOLDS COMBINING ADHESIVE SCM AND IMMOBILIZED CSA CUES
Introduction
Following injury, dedifferentiated Schwann cells in the distal nerve stump, which have lost
contact with the injured axons, begin to over express extracellular matrix molecules (ECM). The
deposited ECM molecules, including laminin and chondroitin sulfate proteoglycans (CSPGs), provide a substrate for axonal elongation.134 As regenerating axons enter the distal portion of the
nerve, they are guided by this substratum. Once Schwann cells regain axonal contact, their expression of the matrix is suppressed. This creates a dynamic environment where the most active
Schwann cells are located most distally in the nerve gap. These substrate-adsorbed factor help
maintain the proper directionality of axonal regeneration.134 In this Chapter, we aim to mimic the
physical and adhesive guidance of native Schwann cells with a bioengineered scaffold featuring
the cues studied in Chapter 2.
Following successful completion of the experiments in the preceding chapter, we aimed
to incorporate the two cues (Chondroitin Sulfate A, CSA and the porcine spinal cord derived matrix
proteins, SCM) into an electrospun nanofibrous scaffold to further improve neurite extension with
the added benefit of a topographical cue. Our objectives for this work were to combine multiple
factors for promoting nerve regeneration (topographically aligned nanofibers and permissive and
inhibitory adhesion molecules) into one bioengineered scaffold, to characterize the scaffold, and
to record the behavior of neurite outgrowth on the scaffold. To immobilize CSA, we modified it
with methacrylate groups prior to blending it into an electrospun nanofibrous scaffold containing
hyaluronic acid (HA) base polymer. HA has already been demonstrated as a beneficial polymer
for neural tissue engineering48, 135 and our lab uses a well-established protocol for spinning it into
nanofibers.136
We previously studied the effects of SCM as an adhesive substrate for nerve outgrowth
along with the effects of soluble CSA (study summarized in Figure 3-1). We then utilized these
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cues in combination with an electrospun HA nanofibrous scaffold. We found significantly improved
neurite growth on fibers blended with either the SCM or the CSA. These results show that, despite
the general opinion that spinal cord has limited healing ability, our isolated material contains ECM
components present in the healthy spinal cord capable of promoting neurite outgrowth. Furthermore, our results show potential utility in the CSPGs expressed following injury and we suggest
that degrading or blocking these molecules completely may be a misguided approach to peripheral nerve repair. Ultimately, we aim to exploit SCM and CSA as part of a tissue engineered PNI
repair strategy that mimics the positive and “negative” cues of the injury site with the long-term
goal of better treating large nerve gap injuries in the clinic.

Figure 3-1. Visual summary of Chapter 2
This figure summarizes the methods and results from the experiments presented in Chapter 2.
Changes in receptor expression and neurite behavior in response to CSA and SCM in these experiments motivated the use of these cues here.
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Experimental
Materials
Macromer synthesis and electrospinning materials include sodium hyaluronate (HA; MW
40kDa; ECM Science), methacrylic anhydride (Sigma), sodium hydroxide (NaOH; Fisher Chemical), polyethylene oxide (PEO; MW 900 kDa; Sigma), Irgacure 2959 (BASF), and 3-(trimethyoxysilyl)propyl methacrylate (Sigma). For all other materials used for cell culture and immunocytochemistry, please refer to Chapter 2.
Macromer Synthesis
Hyaluronic acid (HA) and Chondroitin Sulfate A (CSA) were modified with methacrylate
groups (30% substitution) based on previously described protocols.137, 138 Briefly, 1% (w/v) HA
and 2.5% (w/v) CSA solutions were prepared separately in deionized (DI) H2O. Methacrylic anhydride in molar excess was added dropwise to each of the solutions. The pH of the reaction was
adjusted to 8.0 with 5N NaOH. The reactions were carried out over 2 days with constant stirring
and frequent pH adjustment. Mixtures were purified from unreacted reagents by dialysis (MWCO:
2,000; Spectrum Laboratories) against DI H2O for 2 days with 6 water changes and lyophilized to
recover the final products. In this study, 3g of HA in 300 mL of DI water was reacted with 6.66 mL
methacrylic anhydride to produce methacrylated hyaluronic acid (MeHA) and 1g of CSA in 40 mL
of DI water was reacted with 2 mL methacrylic anhydride to produce methacrylated chondroitin
sulfate (CSMA).
Scaffold Fabrication
MeHA was selected as the base polymer for our scaffolds because it has previously been
demonstrated as a suitable material for DRG neuron culture.136 The base electrospinning solution
and electrospinning parameters are described in detail elsewhere.139 Briefly, 2wt% MeHA, 3wt%
PEO (carrier polymer), and 0.05wt% Irgacure 2959 (photoinitiator) were combined in DI water.
The solution was ejected at 1.2 mL/hr (using a programmable syringe pump, KD Scientific)
through a 6 inch, 18-gauge blunt tip needle charged to 22 kV. Fibers were collected for 45 minutes
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on a grounded, custom built rotating mandrel (2 inch diameter, ~4.5 m/s or ~1700 RPM) positioned 12 cm from the needle. Electrospinning on a rotating mandrel is used to create aligned
fibers for topographical guidance. ~50 μm thick fiber scaffolds were collected on 12 mm round
methacrylated coverslips (3-(trimethoxysilyl)propyl methacrylate according to manufacturer’s protocol) affixed to the mandrel. After fiber collection, scaffolds were carefully removed from the
mandrel and crosslinked with 10 mW/cm2 UV light exposure in a nitrogen purged environment for
20 minutes. Scaffolds were rinsed in PBS for 24 hours to remove PEO before use.
Increasing concentrations of CSMA were incorporated into the fibers via blend electrospinning by varying the weight ratio of MeHA to CSMA in the electrospinning solution. Final polymer concentration in the solution remained 2wt%. The amount of CSMA incorporated into the
fibers is indicated by the MeHA/CSMA ratio. For example, pure MeHA fibers are denoted (100/0),
fibers spun from a solution of 1wt% MeHA and 1wt% CSMA (other component concentrations
remain the same) are denoted (50/50), and pure CSMA fibers are denoted (0/100).
CSMA was immobilized into the fibers via the methacrylate sites which are used to attach
photoreactive crosslinkers. The crosslinked material is no longer water soluble. Using polymers
with 30% methacrylation, which has a tensile modulus of ~500 Pa, creates a soft substrate that
is close to the native mechanics of neural tissue and is typically preferred by neurons.140
Blend electrospinning was also used to incorporate SCM into the fibers using the following
spinning solution: 2wt% MeHA, 3wt% PEO, 0.05wt% I2959, in a mixture by volume of 80% DI
H2O and 20% SCM solution (dry SCM dissolved in 0.1M acetic acid).Voltage (22kV), flow rate
(1.2 mL/hr), mandrel speed (4.5 m/s) and distance between the mandrel and needle tip (12 cm)
remained the same during the spinning of all solutions described. Lastly, the SCM was also tested
as an adhesive coating on the MeHA control fibers. 5 μg/cm2 coatings were applied via adsorption
for 4 hours and rinsed 3X with PBS, same as previously described for coating well-plates.
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Fiber Characterization
Scanning electron microscopy (SEM) was used to analyze the surface morphology of the
MeHA fibers. Samples were sputter-coated with gold at 200 Torr for 20 seconds. A JEOL field
emission scanning electron microscope was used with an acceleration voltage of 15 kV. Average
fiber diameter and fiber orientation were evaluated from three distinct images per sample using
ImageJ software. Fiber alignment was determined by measuring individual fiber angles relative to
the horizontal (0°). Each angle measurement was sorted into bins (15°/bin from -90° to 90°). The
mean and median values of the measured angles (n = 15 fibers per image) were calculated.
Percent alignment was defined as the fraction of fibers falling into the bin that also contained the
calculated mean and median angles (adapted from Li 2007).141 These results were corroborated
using measurements collected from the ImageJ plugin OrientationJ.
Cell Culture, Immunofluorescence Microscopy, and Neurite Outgrowth Analysis
Dissociated chick embryo dorsal root ganglia (DRG) neurons were cultured on the scaffolds, fixed, stained and analyzed using identical methods to those described in Chapter 2 Methods. The influence of fiber alignment on individual neurite length was confirmed and the directionality of the neurite outgrowth was measured relative to the fiber direction. A straight line was drawn
from the center of the cell body to the neurite tip. Angles were measured between this line and
the fiber direction (horizontal/0o).
Statistical Analysis
Sample means were compared using a one-way analysis of variance (ANOVA) test and
Fisher’s LSD post hoc analysis. All data is reported as mean ± standard error and any differences
indicate statistical significance (p<0.05), unless otherwise noted.
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Results
CSMA Nanofibers
In this study, we successfully modified CSA with methacrylic anhydride to produce CSMA.
The CSMA was then electrospun into nanofiber blends with methacrylated hyaluronic acid
(MeHA) without any modifications to the base MeHA electrospinning parameters. The concentration density of CS incorporated into the blended fiber scaffolds was estimated by dividing the
mass of the dry CSMA incorporated into each electrospinning solution (4.25, 8.5, 12.75 or 17mg)
by the total surface area of our collection mandrel (340 cm2). Fiber scaffolds were collected on 1
cm2 round coverslips attached to the mandrel. Therefore, the 25, 50, 75, and 100% CSMA fiber
scaffolds contained approximately 12.5, 25, 37.5 and 50 μg CS/cm2, respectively. Individual scaffolds were placed in each well of a 24-well plate for cell experiments. Interestingly, the concentration in the 25% CSMA scaffolds (12.5 μg/cm2) is very close to that used in the soluble CSA
studies (10 μg/cm2).
DRG neurons were cultured for 2 days on fibers containing increasing concentrations of
CSMA. Final neurite lengths were measured from fluorescence micrographs and we found that
at low levels of CSMA incorporation (25%), neurites were significantly longer than the MeHA control fibers. This result might be attributed to the CSMA retaining its ability to influence syndecan
receptor expression (results from Chapter 2). Furthermore, this result agrees with other studies
that have shown low levels of immobilized CSPG do not impede neurite outgrowth142 and can
even increase growth cone movement.99 As the concentration of CSMA in the fibers increased
beyond 25%, average neurite lengths decreased. Neurons grown on the pure CSMA fibers had
significantly shorter neurite lengths than the MeHA controls, indicating some level of inhibition
was still retained in the CS cue following its chemical modification. Nevertheless, neurons were
still able to attach and grow on the purely CSMA fibers. This result is not surprising because
CSPGs are a normal part of healthy ECM. Despite their overexpression following injury, CSPGs
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are still capable of being bound by syndecans, integrins, and other receptors on the neurons.
Complete neurite length results are reported in Figure 3-2.

Figure 3-2. Quantified neurite outgrowth on MeHA/CSMA blended fibers
The effect of increasing CSMA concentration in MeHA and CSMA blended fibers on average
neurite length from DRGs cultured on nanofiber scaffolds for 2 days. Neurons grown on
MeHA/CSMA fibers in a 75/25 ratio were significantly longer than all other conditions, # p<0.05.
Neurons grown on pure CSMA fibers (0/100) were also significantly shorter than pure MeHA
control fibers (100/0), + p<0.05. n49 neurites measured per condition.
(© IOP Publishing. Reproduced with permission. All rights reserved. https://doi.org/10.1088/1748605X/aa61d1)

SCM Nanofibers
In addition to incorporating CSMA into the MeHA nanofibers, we also wanted to create
nanofibers that incorporated the SCM cue. This was accomplished in two ways, as an adsorbed
coating on the MeHA fibers, and blended into the polymer solution prior to electrospinning. The
effects of incorporating SCM into the fibers on final neurite outgrowth from the DRG neurons is
reported in Figure 3-3. Both methods of incorporation had significantly improved neurite outgrowth over the MeHA only controls. Example fluorescence micrographs of the DRG neurons
grown on the different scaffolds as well as scanning electron micrographs of the fibers are shown
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in Figure 3-4. Fibril proteins of native extracellular matrix provide guiding structures in the nanometer range (50-500nm). The nanofibers produced here had an average diameter of 250  78
nm. The addition of the CSMA and SCM cues had no statistically significant influence on average
fiber diameter or alignment.

Figure 3-3. Quantified neurite outgrowth on SCM incorporated fibers
The effect of incorporating SCM into nanofibrous scaffolds on average neurite length from DRGs
neurons grown on the scaffolds for 2 days. Neurons grown on MeHA fibers coated with 5 μg/cm2
SCM solution (‘+SCM coating’) had significantly longer neurites than cells on the MeHA only control fibers, *p<0.05. Neurons grown on MeHA and SCM blended fibers (‘+SCM blend’) were also
significantly longer than the controls and produced the longest neurites overall, **p<0.01. n58
neurites measured per condition.
(© IOP Publishing. Reproduced with permission. All rights reserved. https://doi.org/10.1088/1748605X/aa61d1)
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Figure 3-4. Fluorescence micrographs of neurite growth on the blended fibers scaffolds
Fluorescence micrographs of DRG neurons grown on blended nanofiber scaffolds for two days
then stained with anti-neurofilament and DAPI. CSMA and SCM cues improve neurite outgrowth
over MeHA only control fibers. Conditions are (A) MeHA control, (B) MeHA/CSMA (75/25)
blended fibers, (C) MeHA + SCM blended fibers, (D) MeHA fibers + SCM coating. The insets
show scanning electron micrographs (SEM) of fiber morphology. The SCM coating procedure (D)
involves soaking the MeHA only scaffolds (A) in the SCM solution but SEM was not available for
hydrated samples. Scale bars = 100 μm for FM and 10 μm for SEM.
(© IOP Publishing. Reproduced with permission. All rights reserved. https://doi.org/10.1088/1748605X/aa61d1)

53

Discussion
Following peripheral nerve injury (PNI), regenerating axons encounter CSPGs in both soluble and adhered forms. Soluble CSA and immobilized CSA (or CS that is protein bound, CSPG)
can interact with regenerating neurons, and other substrate proteins in different ways. 130 Therefore, we immobilized our CS cue within the MeHA nanofibers. Given the flow cytometry results
with soluble CSA (increased Syndecan-3), we hypothesized that low levels of immobilized CSA
may also be beneficial for neuron growth. Therefore, we needed a way to present the CS cue
longer term, especially if it was to ultimately be part of an implantable PNI repair strategy. We
utilized the same reaction we already had experience with for methacrylating the HA. We found
that our hypothesis was confirmed with our MeHA/CSMA (75/25) fiber results. Neurons grown on
these scaffolds were an average of 35 μm longer than on the control fibers. Therefore, we planned
to move forward with this particular blend in future experiments.
Hyaluronic acid is a popular polymer for neural tissue engineered regeneration strategies
because it is naturally-derived, enzymatically degraded (via hyaluronidases in the body), and easily modified.135 Another reason for selecting HA as our base polymer is that we can spin it out of
water as opposed to harsh, volatile solvents. Water should better preserve the bioactivity of chemical cues such as the SCM and CSMA. Methacrylated chondroitin sulfate A (CSMA) and methacrylated hyaluronic acid (MeHA) have been combined previously in hydrogel form for tissue engineering.143, 144 Additionally, decellularized porcine spinal cords have been explored for nerve regeneration strategies and have also been fabricated primarily into hydrogels. 113, 145 CSMA has
previously been electrospun into nanofibrous scaffolds146 but not uniquely in combination with
MeHA. Similarly, decellularized matrix, including from spinal cord, has also been electrospun before, but is most often blended into gelatin or PLGA fibers.147, 148 Our combination of the SCM with
MeHA is a unique biomaterial and its use for nerve regeneration is a unique application of these
two materials together.
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With an average neurite length of nearly 270μm in 48 hours, the SCM blended fibers produced the longest outgrowth in this study. Interestingly, the increase in neurite length on the SCM
blended fibers over the MeHA controls (269.4 – 203.5 μm = ~66 μm increase) was very similar to
the increase seen on the SCM substrate compared to the plastic controls (213.1 – 146.2 μm =
~67 μm increase) from our previous work (Chapter 2 Results). This result helps verify the growth
promoting effects of the SCM and suggests that its activity was not diminished during the electrospinning process.
The overall average neurite lengths were longer on the SCM blended scaffolds than the
SCM coated plates (results of Chapter 2) because of the added benefit of the topographical guidance provided by the aligned nanofibers. Only aligned nanofibers were evaluated here because
of their known ability to accelerate neurite growth.47 However, we have previously confirmed this
by testing DRG outgrowth on aligned and non-aligned electrospun MeHA. Additionally, we confirmed that neurites grow in the direction of alignment.
Aligned MeHA nanofibers induced significantly longer neurites than the non-aligned scaffolds, confirming the ability to accelerate outgrowth. Furthermore, the aligned fibers also directed
neurite growth with >50% of neurites extending within ±15 degrees of the fiber direction. The
neurite angle distribution on non-aligned scaffolds was much more random. Full results summarized in Figure 3-5.
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Figure 3-5. Characterization of aligned fiber scaffolds and their effect on neurite growth
A) SEM images of non-aligned (700 rpm) and aligned (2500 rpm) MeHA nanofibers. Scale 10 μm.
B) Dissociated DRGs grown for 24 hours on nanofibers. Stained with DAPI and Anti-neurofilament.
Scale 100 μm. C) Quantification of neurite outgrowth revealing accelerated growth on aligned vs.
non-aligned fibers. * p < 0.01, Mann-Whitney ranked-sum test. D) Distribution of neurite angles relative to the fiber direction for aligned scaffolds and to an arbitrary reference angle for non-aligned. n
= 45 neurons measured per condition.
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It has previously been suggested that a ratio of growth-promoting to growth-inhibiting cues
in a substratum is key to success following nerve injury.130 Therefore, we were interested in testing
the combined effects of SCM, CSMA and MeHA to see if they could work synergistically to promote neuron growth. We created two scaffold combinations and cultured the DRG neurons on
them as described previously (full methods in Chapter 2). Specifically, we tested 75/25
MeHA/CSMA blended fibers with a SCM coating (5μg/cm2) and created tri-blended fibers of all
three polymers (75/25 MeHA/CSMA where DI H2O was replaced by the dissolved SCM solution;
see SCM blended fiber method above). Unfortunately, we did not see statistically improved neurite outgrowth with either of these combinations (data not shown). We predict that the SCM coating may have masked the influence of the CSMA. Furthermore, the tri-blended fibers may not
have an optimized combination of the two chemical cues.
In the future, we plan to combine these cues in a variety of different concentrations and
different presentation styles to systematically identify a potentially useful combination. We are
particularly interested in delivering the cues as patterned spots or gradients because of the known
benefits of physical and chemical gradients for directing and accelerating neuronal growth and
migration.62 We hypothesize that normally inhibitory CSA, can be exploited for directing axon regeneration especially when co-delivered with the growth-permissive SCM. We predict that opposing linear gradients of the two adhesive cues within the fibers would promote the most robust and
direct neurite outgrowth in the direction of increasing SCM and decreasing CSA. Our preliminary
work on electrospun gradient formation, with RGD peptide conjugated MeHA, is provided in Appendix A. In the future, we hope to adapt/expand this work to incorporate the CS and SCM cues.
Finally, in this study we aimed to analyze neurite extension and retraction behavior on the
fibers using time lapse video. The cells were harvested, trypsinized, and mechanically dissociated
using the same methods as described in Chapter 2. To visualize the neurites, which have similar
diameter to the individual nanofibers, time lapse imaging must be conducted under a fluorescence
filter and not under bright field as was done previously.
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Prior to time lapse imaging, the neurons were made to fluoresce in one of the following
ways: transfected with green fluorescent plasmid (GFP) using Amaxa® Chicken Neuron Nucleofector® Kits (Lonza), incubated with Vybrant Green DiO dye or CellTracker Red CMPTX dye
(both Molecular Probes, Life Technologies), or transfected with CellLight Actin-GFP BacMam 2.0
(Molecular Probes, Life Technologies). All transfection and/or dying was carried out per the manufacturers’ protocols.
Our dissociated DRGs were successfully labeled using all of the methods. However, several issues arose when trying to capture the neurite outgrowth in real time. First, all the fluorescent
markers were susceptible to bleaching over the course of the time lapse period (12 hours). Even
with images captured only once every 10 minutes, cells were often too dim to see anymore after
the first few images. Secondly, most of the markers led to increased apoptosis in the neurons,
suggesting that the cells were under stress. Therefore, any outgrowth captured from these cells
likely would not reflect “normal” neurite behavior. Full outcomes are summarized in Table 3-1.

Product Name

Labeling
Mechanism

Amaxa®
Chicken Neuron
Electroporation
Nucleofector®
Kit with GFP

Cell Staining Conditions

Methods (Concentrations;
Outcomes
Incubation
times) Attempted

Suspension

2μg GFP Vector
per 100μL cell
suspension

Vybrant Green
DiO

Lipophilic dye
stains cell
membrane

Both

5μL dye per 1mL
culture media; 230 minutes

CellTracker
Red CMPTX

Membrane
permeable,
cytoplasmic
stain

Both

0.25-5μM dye in
media; 15-45
minutes

Transfection rates
<30%; required >2
million cells for
each attempt
Stained cell bodies
but not the neurites; severe photobleaching
Increased apoptosis/cell death

CellLight Actin10-50 particles
Increased apoptoGFP BacMam
Viral transfection Plated
per cell; 12-24
sis/cell death
2.0
hours
Table 3-1. Fluorescence labeling techniques attempted for live cell imaging on the fibers
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Conclusions
In this study, we successfully incorporated the SCM and methacrylated CSA into electrospun HA scaffolds. These added adhesive cues provide improved neurite outgrowth over HA
nanofibers alone. The objective of this research is not only to identify positive and negative cues
for promoting neuron growth but to ultimately utilize these cues as part of an implantable tissue
engineered device. Our long-term goal is to improve treatments for large peripheral nerve gaps
where normal repair processes can be delayed or deficient and current treatments are insufficient
to achieve full recovery. In the next chapter, we test the effects of the CSA, SCM, and HA nanofibers on macrophage and Schwann cell phenotype as these cells are critical to successful peripheral nerve repair.
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CHAPTER 4: A BIOMATERIALS-BASED APPROACH FOR ACCELERATING MACROPHAGE AND SCHWANN CELL PHENOTYPE TRANSITION AFTER PNI
Introduction
Many tissue engineering approaches to treating peripheral nerve injury (PNI) show great
promise in vitro but test poorly in animal models compared to autografts.7, 43 These poor outcomes
may result from failure to study the response of other cell types present in the PNI microenvironment prior to in vivo studies. The purpose of this study was to evaluate the ability of our biomaterials cues, previously demonstrated to have growth promoting effects on dorsal root ganglia (DRG)
neurons149, to modulate the phenotypes of macrophages and Schwann cells (SCs). Specifically,
we explored the effects of Chondroitin sulfate A (CSA; soluble cue), porcine spinal cord extracellular matrix (SCM; adhesive cue), and aligned hyaluronic acid (HA) nanofibers (topographical
cue). Our primary objective was to direct and accelerate the macrophages transition from a classically activated/pro-inflammatory state to an alternatively activated/pro-healing state using one
or more of these cues. Similarly, we aimed to use the biomaterials cues to direct and accelerate
the transition of Schwann cells from an immature state following injury to a mature and pro-myelinating one.
The Bellamkonda group was one of the first to study the effect of modulating macrophage
phenotype for peripheral nerve repair. Over the past two decades, Bellamkonda and colleagues
have studied several enhancements to basic nerve guide conduits for treating large peripheral
nerve gaps. Some of the chemical and physical cues they’ve explored include material stiffness150, channels151, fiber alignment45, fibronectin152, laminin and nerve growth factor,153 and different combinations of these cues just to name a few. In a 2012 study, the group successfully
used interferon-y and IL-4 to polarize macrophages towards an M1 or M2 phenotype, respectively.
Cytokines were delivered in vitro or released from an agarose hydrogel in an in vivo rat sciatic
nerve injury model. Polarization to the M2 phenotype enhanced Schwann cell infiltration and axonal extensions into the nerve gap.154 Furthermore, in the IL-4 (induces M2) scaffolds, axonal
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growth rate, defined as axon length into the nerve gap as a function of time, was faster by a factor
of 2 compared to their previous studies with other types of growth enhancing cues. The group
concluded that regulating macrophage phenotype minimizes the need for other more sophisticated NGC modifications and might alone be sufficient to influence long-term regenerative outcomes without the need to modulate any other inhibitory factors present in the PNI environment.
CSGPs are one such inhibitory factor present following PNI. In Chapters 2 and 3, we demonstrated that soluble and adhesive CS cues, while typically inhibitory, can positively influence neuron growth and receptor expression.149 Therefore, we wanted to explore the effect of CSA on
macrophage and Schwann cell phenotypes. Ideally, the CSA would not exacerbate the cells inflammatory responses. The Bellamkonda study was especially motivating to the work in this
Chapter. The ability to regulate macrophage phenotype with biomaterials would be a great advantage to promoting nerve repair even over the use of immunomodulatory cytokines.
The effect of topography on macrophage activation state has gained popularity in recent
years. Early work focused on altering the surface roughness of orthopedic implants to improve
wound healing155 and modification of titanium surfaces remains a key focus in the field.156, 157 More
recently, macrophage activation has also been studied in response to smooth and sandblasted/acid etched epoxy158, nanogrooved silicon wafers159, convex and concave micro-structured silicone160, and electrospun poly-lactic acid microfibers161 to name a few examples. Most
groups have found that topographical cues minimize inflammatory responses in the cells when
compared to smooth controls. More groups have reported a reduction in pro-inflammatory cytokines than changes in gene expression or morphology. However, it has been shown that both
minimized inflammatory response and peak cell alignment tend to occur on features approximately 400-500nm in width.157, 162 Despite these promising results, very few studies have looked
at both aligned nanofibers, especially of a natural polymer (e.g. HA), and ECM molecules (e.g.
CSA and SCM) to modulate the progression of macrophage phenotype over multiple time points.
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Additionally, no macrophages studies could be found that also evaluated the effects of their materials on Schwann cell phenotype.
A pioneering study by Chew et al. in 2008, tested the ability of aligned and non-aligned
electrospun poly-ε-caprolactone (PCL) fibers to encourage human Schwann cell maturation. 81
Their real-time-PCR analyses revealed an upregulation of early myelination marker, P0, and
downregulation of immature marker, NCAM-1, for cells grown on PCL fibers compared to PCL
films. The authors hypothesized that functional changes in the cells may be a result of morphological changes induced by the alignment of the fibers. In this study, we test not only the effects
of nanofibers and SCM on the cells gene expression but also on the cells morphology and cytokine release. Chew et al. demonstrated what promise electrospun fibers hold for enhancing
Schwann cell maturation and recommended such scaffolds be used as a platform for transplantation of 'primed' cells for improving peripheral nerve regeneration. However, no follow up studies
from the group could be found.
In this study, we hypothesized that one or more of our biomaterials cues would accelerate
the macrophages return to a resting state, following classical activation (M1) with lipopolysaccharide (LPS) and/or direct the cells towards an alternative activation (M2) state. Analogously, we
hypothesized our cues would accelerate the SCs transition to a mature/pro-myelinating state,
following treatment with LPS, used here to mimic immaturity/injury. Peak inflammatory and neuroinflammatory response of the macrophages and SCs occurs around day 4 following PNI. 163
However, by introducing hyaluronic acid nanofibers (used here to mimic aligned SCs of the Bands
of Bungner), it is predicted that we can accelerate (48 hours or less) a switch in the Schwann cells
to a pro-myelinating state. Schwann cells are also responsible for laying down newly synthesized
extracellular matrix proteins. The delivery of our novel SCM substrate is hypothesized to accelerate the cells towards maturity as these ECM cues would already be in place. To test our hypotheses, cell phenotypes were functionally assessed at three time points following LPS stimulation.
Quantified reverse transcription polymerase chain reaction (qRT-PCR), immunofluorescence (IF),
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and sandwich-ELISA based antibody arrays were used to measure changes in mRNA expression,
morphology, and cytokine release, respectively.
Experimental
Methods for the spinal cord matrix (SCM) isolation and coating procedure and for electrospinning the hyaluronic acid scaffolds are provided in Chapters 2 and 3, respectively.
Cell Culture
Macrophages
RAW 264.7 murine blood-derived macrophages (generously provide by Dr. Olivia Merkel)
were cultured on tissue culture plastic (TCP) in Dulbecco’s modified eagle medium (DMEM,
Fisher) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologics), 1% glutamine and
1% Penstrep. Cells were maintained at 37C in a humidified environment with 5% CO2. Cells were
split every 2-3 days using Accutase (MP Biomedicals) until ready for use (passages 8-13). Macrophages were induced to a classically activated state using 1 μg/mL lipopolysaccharide (LPS,
Sigma) delivered in the media. To test the ability of our chemical and topographical cues to mitigate M1 activation, and/or induce M2 activation, LPS-stimulated macrophages were seeded
(40,000 cells/cm2) on TCP (positive/M1 phenotype control), SCM coating (10μg/cm2), HA electrospun nanofibers, or TCP with 10μg/mL of CSA in the media. Cells cultured on TCP without any
LPS stimulation served as the negative control.
Schwann Cells
S16 Schwann cells, derived from rat sciatic nerve, were purchased from the American
Type Culture Collection (ATCC; CRL-2941). The SCs were maintained using the same conditions
and media formulation as the macrophages (see above). The cells were used during the same
number of passages. LPS stimulation and culture with our chemical and topographical cues was
also conducted using the same methods. The only difference from macrophage conditions was
that during maintenance of the SC cultures (not during experimentation), TCP was treated with
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1.5 μg/cm2 poly-L-lysine (PLL; Sigma P-9155) per ATCC guidelines. PLL was used to maintain
expansion of the SCs.
mRNA Expression (qRT-PCR)
At 12, 24, and 48 hours after cell seeding, RNA was isolated from the cells using a
GeneJET RNA purification kit (K0761; ThermoFisher). cDNA (200 ng/sample, measured with a
Qubit 2.0 Fluorometer, Q32866, Life Technologies) was prepared using a Taqman Reverse Transcription kit (N8080234, Applied Biosystems) and a thermocycler (2720; Applied Biosystems).
Samples were run for 10 minutes at 25C, 30 minutes at 48C, and finally held at 4C until further
analysis. Samples (2μL) were combined with forward and reverse primers (0.2μL), RNase-free
water (7.6μL), and Power SYBR Green PCR Master Mix (10μL; Thermo) in wells of a MicroAmp
Fast Optical 96-well reaction plate. Quantitative real time polymerase chain reaction (qRT-PCR)
was conducted using a StepOnePlusTM Real-Time PCR Instrument (4376600; Applied Biosystems) with the accompanying StepOne PCR software (v 2.2.2; Applied Biosystems). Fold
changes were quantified using the comparative 2-ΔΔCt method164 and standardized between three
biological replicates as described by Willems et al 2008.165 Fold changes are reported relative to
cells without LPS treatment and normalized to an endogenous housekeeping gene. All reactions
were conducted in triplicate. Primer sets were selected from the Harvard Medical School PrimerBank166 and were ordered from Invitrogen Custom DNA Oligos. Complete primer list provided
in Table 4-1.
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Cell Type

RAW 264.7
Macrophages

S16 Schwann
Cells

Gene Name

Accession #

Primer Sequence (5'  3')

Description

Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH)

NM_008084

F: AGGTCGGTGTGAACGGATTTG
R: GGGGTCGTTGATGGCAACA

Housekeeping

Inducible Nitric Oxide
Synthase (iNOS)

NM_010927

F: GGAGTGACGGCAAACATGACT
R: TCGATGCACAACTGGGTGAAC

M1 (Classic
Activation)

Arginase 1 (Arg1)

NM_007482

F: CTCCAAGCCAAAGTCCTTAGAG
R: GGAGCTGTCATTAGGGACATCA

M2 (Alternative
Activation)

Beta-actin

NM_031144

F: CCTCTATGCCAACACAGT
R: AGCCACCAATCCACACAG

Housekeeping

Glial Fibrillary Acidic Protein
NM_017009
(GFAP)

F: TCCTGGAACAGCAAAACAAG
R: CAGCCTCAGGTTGGTTTCAT

Neural Cell Adhesion
Molecule (NCAM)

F: GGGAGGATGCTGTGATTGTCT
R: GCAGGTAGTTGTTGGACAGGAC

NM_031521

Nerve Growth Factor Receptor
NM_012610
(p75)

F: GGTGATGGCAACCTCTACAGT
R: CCTCGTGGGTAAAGGAGTCTA

Myelin Basic Protein (MBP)

NM_017026

F: AGAGTCCGACGAGCTTCAGA
R: CAGGTACTTGGATCGCTGTG

Octamer Transcriptin Factor
(Oct6)

NM_138838

F: CTCCTGGGGTCCTTCTAACT
R: TTATACACAGATGCGGCTCTC

Early Growth Response 2
(Krox20)

NM_053633

F: GCCCCTTTGACCAGATGAAC
R: GGAGAATTTGCCCATGTAAGTG

Immature
Markers

Pro-myelinating/
Mature Markers

Table 4-1. List of gene names, functions, and primer sequences used for PCR

Morphological Analysis
Following culture as outlined above, cells were fixed (4% paraformaldehyde for 30
minutes) and stained with DAPI and FITC-Phalloidin (Cytoskeleton Inc.) to visualize cell nuclei
and F-actin filaments of the cytoskeleton, respectively. Images were taken on a Nikon Eclipse
inverted fluorescent microscope. Five random positions were imaged in each of three replicates
of each test condition, in three independent experiments, for a total of 45 images. A minimum of
100 cells were measured from the images and the following were quantified using NIS Elements
automatic measurement feature: cell area (μm2), cell elongation, and cell circularity (form factor).
The thresholding tool was used to outline each object/cell. Cells that were on top of one another
or that were at the edge of the field of view were manually excluded.
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Proliferation
AlamarBlue reagent (Invitrogen was used to evaluate macrophage and Schwann cell proliferation in response to the same culture conditions outlined above. AlamarBlue was selected
because it is a non-toxic, aqueous dye that can be used to assess net cell numbers over several
time points within the same culture. Cell proliferation was measured by adding 10% (by volume)
AlamarBlue to each well and incubating for 3.5h (S16) or 5h (RAW 264.7) at 37C. Incubation
times were determined empirically by finding a length of incubation that produced linear correlation between cell count and AlamarBlue absorbance (R2 > 0.96 for both cell lines), verifying the
validity of the assay. After incubation, 100 μL media samples were moved to a 96-well plate in
triplicate. Absorbance was read at 570 and 600 nm in a MultiskanGO spectrophotometer. Percent
AlamarBlue reduction was calculated using the correction factor method as described in the manufacturer’s instructions. Data represent mean ± standard error from three independent experiments.
Cytokine Release
G-Series Mouse Cytokine Array 1 (macrophages) and Rat Cytokine Array 2 (Schwann
cells) were purchased from RayBiotech (Norcross, GA) and performed according to the manufacturer’s instructions. The array was incubated with undiluted cell culture supernatant overnight.
Supernatants were produced from 1 x 105 cells/cm2 in 1mL of culture medium. Supernatants were
collected 12, 24, and 48 hours after seeding and centrifuged for 2 minutes at 8,000 rpm to remove
any debris. DMEM supplemented with 10% FBS was used to determine and remove background
signal contributed by cytokines in the media. Signal intensity readings obtained for each cytokine
were normalized to the positive control contained within the array (maximum possible signal intensity). Cytokine release is presented as median fluorescence intensity (from 4 replicates) of
each of the tested conditions and was adjusted for relative cell number using results from the
proliferation assay. Laser scanning and data extraction were performed by RayBiotech, Inc. Data
analysis was conducted in Microsoft Excel and ImageJ.
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Statistical Analyses
Sample means were compared using a one-way analysis of variance (ANOVA) test and
Fisher’s LSD post hoc analysis. All data is reported as mean ± standard error and any differences
indicate at least statistical significance (p<0.05), unless otherwise noted.
Results
Changes in Macrophage Activation
RAW 264.7 macrophages were stimulated with 1 μg/mL of LPS to mimic the cells’ proinflammatory response following injury, also referred to as classical activation (or M1). This initial
response is often characterized by increased expression of inducible nitric oxide synthase (iNOS)
as well as morphological changes in the macrophages to make them more capable of clearing
cellular and tissue debris at the injury site. Cells also release pro-inflammatory cytokines including
tumor necrosis factor alpha (TNF-α) and the following interleukins (IL-1, IL-6, IL-12).167 Macrophages can transition to a pro-healing state, or alternative activation (M2), at later stages of repair
and this transition can be facilitated with chemical cues (e.g. IL-4, IL-13, TGF-b). Here we have
explored the ability of our adhesive and topographical cues, previously studied for their effects on
neurons, on macrophage mRNA expression, morphology, proliferation, and cytokine release.
mRNA Expression
Expression of iNOS (M1) and Arginase 1 (M2) in the RAW 264.7 macrophages was measured by qRT-PCR at three time points following LPS stimulation. Results are reported as fold
changes relative to unstimulated cells and normalized to the endogenous control gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH). As expected, LPS stimulation resulted in a
strong upregulation of iNOS compared to the untreated controls. At 12 hours, iNOS expression
was statistical similar between LPS-stimulated cells cultured with the CSA, SCM, and HA fiber
cues and LPS-stimulated cells on plastic. However, some of our cues mitigated this upregulation
at longer time points. 24 hours after stimulation, cells cultured on the HA nanofibers with LPS had
significantly lower iNOS expression than cells on plastic with LPS (p<0.05; n=3). This significant
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decrease was maintained through 48 hours (p<0.01; n=3). Furthermore, by 48 hours the cells
cultured on the SCM coating with LPS also had significantly reduced iNOS expression (p<0.05;
n=3). These results suggest that the SCM and HA nanofibers can suppress the effects of the LPS
in as little as 48 hours when normal macrophage transition from M1 (following injury) towards M2
can take much longer. These results support our hypothesis that our cues would accelerate the
return of the macrophages to a resting state.
Despite having the known effect of skewing macrophages towards the M1 phenotype, LPS
treatment also produced a modest increase (~10-fold) in expression of the M2 gene, Arg1. This
result was observed with all of our experimental cues and has also been observed in literature.158
While none of the cues induced a statistically significant increase in Arg1, the cues appear to
have no net negative effects on the cells, such as decreasing Arg1 expression.
Both iNOS and Arg1 were expressed in an oscillating pattern with a dip in expression
levels at 24 hours compared to the other two time points. This pattern of expression has been
observed previously in the literature and is described in more detail in the Discussion section.
Complete results are summarized in Figure 4-1.
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Figure 4-1. Summarized changes in macrophage gene expression measured with PCR
Changes in iNOS (A) and Arg1 (B) gene expression in RAW 264.7 macrophages. Cells cultured with the cues for 12, 24, or 48 hours following LPS treatment. Fold change relative to untreated (-LPS) cells. Internal control gene = GAPDH. Means ± SEM. n = 3 biological replicates
(each run in triplicate). *p<0.05; **p<0.01; one-way ANOVA + Fisher’s LSD post hoc.

Morphology
Changes in cell shape have long been associated with changes in cell function. Therefore,
macrophage morphology has previously been studied as an indicator of M1 and M2 activation
states.78 Macrophage morphology, and its effects on activation state, have been studied in response to physical cues such as topography157 and stiffness168, 169 as well as many soluble factors.
M1 activation is broadly defined by large, flattened cellular morphology while M2-polarized cells
tend to assume a more elongated and spindle-like shape.78
In this study, the most significant changes in mRNA expression induced by our cues were
observed after 48 hours of culture, therefore we selected 48 hours as the time point to conduct
our morphological analysis. Cells were fixed and stained with FITC-phalloidin and DAPI to visual
actin filaments and cell nuclei, respectively. Fluorescence micrographs of the cells grown in each
of the culture conditions are shown in Figure 4-2. NIS elements software was used to measure
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the average cell area, elongation factor, and form factor/circularity of the macrophages as defined
in Figure 4-3A.

Figure 4-2. Fluorescence micrographs of RAW 264.7 macrophage morphologies
Fluorescence microscopy images of RAW 264.7 macrophages grown for 48 hours in the culture conditions indicated. Phalloidin and DAPI stain actin filaments and cell nuclei, respectively. Scale bar 50 μm for all images.

LPS treatment caused the macrophages to become large, flattened, and stellated, all characteristics of M1 activation. LPS significantly increased cell area for all conditions except the cells
grown on the nanofibers. Cells grown on the nanofibers had statistically similar cell area with or
without LPS treatment, suggesting possible suppression of the effects of LPS. However, cell area
on the fibers was still slightly larger (439 ± 21 μm2) than the TCP controls (221 ± 4 μm2). Cells
were also slightly larger in area in the presence of CSA (370 ± 11 μm2). Cells grown on the SCM
coating had statistically similar area to the TCP controls without LPS treatment.
An elongation factor of 1 indicates a perfectly circular cell. Our control macrophages (TCPLPS) assumed a primarily oval shape (1.36 ± 0.03). The LPS treatment had no significant effect
on cell elongation. However, cells grown on the SCM coating (-LPS: 1.50 ± 0.02; +LPS: 1.47 ±
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0.03) had significantly increased cell elongation (p<0.05) compared to the TCP controls suggesting a possible benefit to the cells. Elongated and spindle-shaped morphology can be indicative of
M2 activation in macrophages.78 This result supports our hypothesis that at least one of the biomaterials cues would direct cells towards an M2 phenotype and this is an earlier marker of that.
We predict that at longer culture times, or at higher SCM concentrations, this result may be more
pronounced.
Form factor indicates the circularity and compactness of a cell, with 1 indicating perfectly
round and 0 indicating a perfectly “star-shaped” cell. LPS treatment significantly reduced cell circularity for all conditions except the cells grown on the nanofibers. Cells grown on the HA nanofibers were very rounded and maintained a statistically similar form factor to the TCP condition
with or without LPS treatment. This result again suggests possible mitigation of LPS effects by
the fibers. Cells on the SCM also had reduced circularity compared to the TCP control (n.s.) but
this is most likely a “side effect” of the increased elongation of these cells rather than a true indicator of M1 morphology (i.e. stellation produced by LPS). Complete, quantified morphological
measurements for the macrophages are summarized in Figure 4-3.
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Figure 4-3. Quantified morphological features of RAW 264.7 macrophages
(A) Measurement parameters used to conduct morphological analysis. Graphs of (B) average
cell area, (C) average cell elongation factor, and (D) average cell circularity/form factor for the
RAW 264.7 macrophages grown for 48 hours in the indicated culture conditions. All data reported as mean ± SEM. n > 45 cells measured per condition. *p<0.05; ***p<0.001 one-way
ANOVA with Tukey’s HSD post hoc.

Proliferation
The effect of the different biomaterials cues on macrophage proliferation was evaluated
using an AlamarBlue assay. Results are provided in Figure 4-4.
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Figure 4-4. RAW 264.7 proliferation results
Cell numbers are increasing near linearly for all conditions. Fewer cells are attached to the HA
fibers than in the other conditions and these cells are proliferating more slowly. Excluding the HA
fiber condition, the LPS-treated cells have increased proliferation compared to untreated control
cells through 24 hours. Between 24 and 48 hours proliferation slows for LPS-treated cells most
likely due to limited space while the TCP condition has further increased proliferation.

Percent AlamarBlue reduction was correlated to actual cell numbers using a previously
determined standard curve for the RAW 264.7 line (data not shown). There was a linear correlation between cell count and AlamarBlue absorbance (R2 > 0.96). 50,000 cells were seeded in
each well (100,000 for the HA fiber condition). After a 1 hour attachment time, scaffolds were
moved to new wells and the media was refreshed in all wells. The first measurement at time 0
represents this point right after attachment. The results indicate that closer to 30,000 cells are
adhered to the fibers following the well transfer as opposed to the intended 50,000.
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Excluding the HA fiber condition, the LPS-treated cells had a greater proliferation rate
compared to the untreated TCP control cells through the first 24 hours. This result was expected
because macrophage proliferation is known to strongly increase in response to an inflammatory
challenge
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. However, the untreated cells appear to have increased proliferation between 24

and 48 hours while proliferation in the LPS-treated conditions is slowing. This result is likely due
to space constraints in the wells. Our morphology results showed that the LPS-treated cells had
an average cell area 4 times greater than the untreated cells. Thus, these cells may be approaching confluency which would slow their proliferation.
~40% fewer cells were attached to the HA fibers than the other conditions following the
initial attachment period and moving of the scaffolds. Cells on the HA fibers were also proliferating
linearly but at a slower rate. Cell numbers increased from ~30,000 to 75,000 on the fibers. Therefore, by 48 hours there were ~3 times as many cells on the TCP control than the fibers. Reduced
proliferation could be linked to differences in the cells morphology on the fibers as well as their
reduction in iNOS expression. Slowed proliferation could also indicate a reduced response to the
LPS. Mitigating inflammatory effects of LPS is one of our goals for these biomaterials.
Cytokine Release
To provide additional insight into the activation state of the macrophages in response to
our cues, we used a cytokine antibody array to screen for changes in the release of 20 different
inflammatory factors. 8 of the 20 cytokines were not measured at levels above the media only
(no cells) reference array. These cytokines, which are excluded from the results include: interferon-gamma (IFN-y), interleukins 1b, 3, 4, 5, 13 and 17, and KC (also known as CXCL1 or neutrophil activating protein 3). Figure 4-5 contains full, semi-quantitative results from the array reported as median fluorescence intensity (MFI) measured from the supernatants of the macrophages seeded with the different materials cues and normalized to their respective cell numbers
form the proliferation assay.
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Figure 4-5. Cytokine release from RAW 264.7 macrophages
Normalized array data of the 12 cytokines that were measured above the DMEM only control are
shown in a “heatmap.” Heatmaps are of median fluorescence intensity (MFI) measured for each
cytokine in each condition/sub-array and adjusted for cell number relative to TCP at each time
point. MFI is already normalized to an internal positive control on the array and background fluorescence from the media is removed.

Overall, the heatmaps show a general pattern of cytokine accumulation over time as indicated by increased MFIs at 48 hours (yellow color indicates a higher concentration of cytokine
compared to blue/black). However, this pattern was not maintained for tumor necrosis factor alpha
(TNFa). Production of TNFa from the untreated macrophages (TCP control) remained constant
while TNFa release from the LPS-treated cells peaked at 12 hours and decreased over time for
the CSA and SCM conditions. This result is promising as TNFa is a cytokine associated with
classical (M1) activation171, 172 and our goal is to direct the cells towards alternative activation.
As expected, the release of several pro-inflammatory cytokines was strongly increased in
response to LPS treatment, especially IL-6 and RANTES. While our biomaterials cues were unable to mitigate the effect of LPS on IL-6 and RANTES production, the cues did not exacerbate the
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release of these M1 cytokines. Interestingly, cells cultured with the SCM or HA fibers had increased production of IL-2 compared to the TCP and TCP+LPS conditions. IL-2 is an anti-inflammatory cytokine with the ability to interfere with IL-6 dependent signaling.173 The ability of these
materials to increase IL-2 production is a potentially exciting result as we aim to reduce classical
activation.
LPS treatment also induced the release of vascular endothelial growth factor (VEGF) from
the macrophages. However, levels of VEGF released from the cells cultured on the SCM+LPS
were reduced compared to TCP+LPS at all time points. VEGF is important for angiogenesis which
must accompany axon regeneration172, however, it has been shown that very high levels of LPSinduced VEGF can lead to pathological conditions and damaging angiogenesis. Suppressing this
effect, as shown here, could be important for regeneration.174
The LPS-treated macrophages cultured on the HA nanofibers had increased release of
most cytokines measured compared to both the TCP and TCP+LPS conditions at all time points.
Increased production of IL-10 and M-CSF is especially promising as these cytokines are associated with alternative macrophage activation. M-CSF is often studied as an exogenous stimulating
factor for directing monocytes towards M2.175-177 Therefore, M-CSF release could potentially work
in a positive feedback loop to continually direct the cells towards a pro-regenerative phenotype.
The most important outcome of these arrays is determining which cytokines to evaluate
with quantitative ELISAs in the future. TNFa, IL-2, VEGF, IL-10, and M-CSF are some of the most
interesting targets for future study with the macrophages and our biomaterials.
Changes in Schwann Cell Maturation
S16 Schwann cells were stimulated with 1 μg/mL of LPS (same as RAW 264.7 macrophages) to induce “dedifferentiation” and inflammatory response in the cells, mimicking injury.
Gene expression and morphology of the SCs were evaluated to determine the effects of LPS.
We hypothesized that LPS would induce significant increases in immature genes (GFAP, NCAM,
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p75) and significant decreases in mature genes (MBP, Oct6, Krox20). We hypothesized that our
cues (CSA, SCM, and HA fibers) would suppress or even reverse these effects of LPS.
Changes in gene expression over the three time points followed a similar, oscillating pattern to the RAW macrophage activation with LPS for every gene except for MBP. However, fold
changes were not significantly different than the untreated control cells. Accordingly, the LPS also
had no significant effects on SC morphology compared to untreated controls. Cells grown on the
PLL coating were large and stellated with significantly increased cell area and significantly reduced form factor compared to TCP. This unipolarized morphology is indicative of immaturity178,
which is ideal for continued proliferation of the line, but not for our intended purpose of SC maturation and pro-myelination. PLL also caused significantly reduced Krox20 expression at 48 hours.
Because of these findings we did not move forward using the LPS in combination with our cues
but rather tested them on their own. Additionally, PLL was only used during maintenance of the
SC cultures and was not used in combination with any of our test conditions. Untreated TCP
served as the control for all remaining SC experiments. Appendix B contains full PCR and morphological data for the Schwann cell responses to LPS and PLL.
mRNA Expression
qRT-PCR was used to determine the effect of the CSA, SCM, and HA nanofibers on transcription of several key proteins related to maturation in the S16 Schwan cells. GFAP is an intermediate filament protein important for SC proliferation. NCAM is a cell surface glycoprotein important for cell-cell binding and alignment during the formation of the Bands of Bungner. p75 is a
low-affinity nerve growth factor receptor. MBP is a protein responsible for maintaining proper myelin structure. Oct6 is a key transcription factor in the early myelination process. Lastly, Krox20 is
a zinc finger transcription factor critical for myelination.179 These markers are broadly characterized as immature (GFAP, NCAM, p75) or mature (MBP, Oct6, Krox20) but changes in transcription of these markers can have many different downstream effects. Changes in expression were
considered significant at p<0.05 when compared to cells cultured on TCP control.
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Treatment of the SCs with soluble CSA had net neutral effects by 48 hours (no significant
change in any of the genes). Cells grown on the SCM had no significant changes in any of the
immature markers by 48 hours. This is a very promising result as our goal is to utilize these cues
to accelerate maturation and myelination following injury. Cells on the SCM had significantly reduced MBP expression, reduced Oct6 expression, and increased Krox20 expression by 48 hours.
This combination of increased and decreased mature markers may also suggest net neutral effects of SCM on the SC phenotype.
SCs cultured on the HA fibers had no significant changes in NCAM expression at any time
point. These cells had increased p75 expression at 12 and 24 hours but expression returned to
control levels by 48 hours. Interestingly, cells cultured on the HA nanofibers had significantly decreased GFAP expression at 24 and 48 hours suggesting a possible shift away from an immature
cellular phenotype.
SCs cultured on the HA fibers had no significant changes in MBP expression. These cells
had significantly increased levels of Oct6 and Krox20 at 24 hours. By 48 hours, expression of
these markers was still increased over the controls, but the changes were no longer statistically
significant (Oct6 p=0.15; Krox20 p=0.18). Interestingly, Krox20 expression steadily increased
over time for the cells grown on the nanofibers. This is a promising result suggesting that HA
nanofibers may induce lasting decreases in GFAP and lasting increases in Krox20, ultimately
leading to a more mature phenotype in the cells.
Some genes exhibited an oscillating expression pattern, similar to what was observed
with the macrophages, but the pattern was less pronounced. Figure 4-6 summarizes the
Schwann cell PCR results. Complete numeric results are provided as bar graphs (mean fold
change ± SEM) in Appendix B.
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Figure 4-6. Summarized PCR results/changes in gene expression in the S16 Schwann cells
↑ upregulation; − no change; ↓ downregulation; Purple = Immature markers; Green = Mature
markers. The number of arrows indicates strength of change. Bolded arrows indicate p<0.05
(one-way ANOVA with Fisher’s LSD post hoc). Changes were calculated relative to TCP control
and normalized to beta-actin (housekeeping gene).

Morphology
Like the study of cell shape for macrophage activation, cellular morphology has also been
explored for its role in Schwann cell activity.180 Following injury, hyper-proliferating Schwann cells
form into aligned columns called the Bands of Bungner. This elongation of the cells’ cytoskeleton
likely induces other changes in cellular activity including the release of mitogens for macrophage
activation and growth factors for axon regeneration.181 Schwann cell morphology has been studied in response to topography82, 182, stiffness183, 184, and soluble factors185. Generally, immature
Schwann cells are characterized by unipolarized morphology while migratory, and pro-regenerative SCs feature bipolar morphology.178
Only the HA nanofibers produced statistically significant differences in SC morphology.
Changes include reduced cell area and form factor and increased elongation, all indicative of the
bipolar phenotype. The SCs elongated in the direction of fiber alignment, putting out one or more
thin extensions to bind the fibers. This rearrangement of the cells’ cytoskeleton and/or enhanced
binding at the ends of the cell tips, may have contributed to the observed differences in gene
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expression on the fibers. Example fluorescence micrographs and quantified morphological parameters are presented in Figure 4-7.
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Figure 4-7. Summarized morphological analysis of S16 Schwann cells
Fluorescence microscopy images of S16 Schwann cells grown for 12 hours stained with Phalloidin (green) and DAPI (blue) and quantified morphological parameters (mean ± SEM; n >120
cells per condition). *p<0.05 one-way ANOVA + Fisher’s LSD post hoc. Arrow indicates direction
of fiber alignment.

Proliferation
The effect of the different biomaterials cues on Schwann cell proliferation was evaluated
using an AlamarBlue assay. Percent AlamarBlue reduction was correlated to actual cell numbers
using a previously determined standard curve for the S16 line (data not shown). There was a
linear correlation between cell count and AlamarBlue absorbance (R2 > 0.98), verifying the validity
of the assay for measuring proliferation. AlamarBlue assay results are provided in Figure 4-8.
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Figure 4-8. Schwann cell proliferation results
The effects of the different biomaterials cues on S16 proliferation were evaluated using an Alamar
Blue assay. Cell numbers increase linearly for all conditions but proliferation rate is slower for cells
grown on the HA nanofibers.

50,000 cells were seeded in each well (100,000 for HA fiber condition). The S16 cells
required 12 hours to fully attach to the HA fibers. After this attachment period, scaffolds were
moved to a fresh well of the plate, leaving behind any cells that may have settled under the scaffold, and media was refreshed on all the tested conditions. Note that proliferation and cytokine
production (next section) were measured at 12, 24 and 48 hours after this media change but at
24, 36, and 60 hours after the SCs were initially seeded, which differs slightly from the macrophage data.
Cell numbers are increasing linearly for SCs grown on TCP (control), SCM-coated TCP,
and TCP+soluble CSA. Cell numbers are increasing from the 50,000 seeded at the zero time
point to ~150,000 cells at 48 hours. ~40% fewer cells are attached to the HA fibers than the other
conditions following the initial attachment period and moving of the scaffolds. Cells on the HA
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fibers are also proliferating linearly but at a slower rate. Cell numbers are doubling from ~30,000
to 60,000 on the fibers. Therefore, by 48 hours there are ~2.5 times as many cells on the TCP
control than the fibers. Results of the proliferation assay were used to normalize the following
cytokine release data to cell number.
Cytokine Release
The ability of CSA, SCM, and the HA fibers to affect cytokine release from the S16
Schwann cells was evaluated by measuring the secretion of 34 cytokines using the RayBiotech
Rat Cytokine Antibody Array 2. Array scanning and data extraction were provided by RayBiotech.
We analyzed the raw fluorescence intensity data using ImageJ and Excel. 17 of the 34 cytokines
were not expressed at levels above the media only (no cells) reference array. These cytokines,
which are excluded from the results include: CINC-1, CINC-2alpha, CINC-3, Fas ligand, Fractalkine, IL-1a, IL-1b, IL-1 R6, IL-10, Leptin, LIX, L-selectin, MIP-3alpha, MMP-8, Prolactin, RAGE,
and Thymus chemokine. Figure 4-9 contains full, semi-quantitative results from the array presented as a heatmap of median fluorescence intensity (MFI) measured from supernatants of the
cells seeded with the different materials cues and normalized to adjusted for differences in proliferation.
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Figure 4-9. Cytokine release from S16 Schwann cells
Cytokine production from Schwann cells cultured with the biomaterials cues presented as a
heatmap of median fluorescence intensity (MFI) adjusted for cell number relative to TCP at each
time point. MFI is already normalized to an internal positive control on the array and background
fluorescence from the media is removed.

The first observation to be drawn from Figure 4-9 is that cytokine concentrations in the
supernatants collected from the SCs were much lower overall compared to cytokine concentrations in supernatant collected from the macrophages as evidenced by the primarily blue color.
Only MCP-1 and VEGF were measured at high levels across all time points and for all conditions. Interestingly, the release of Agrin from the SCs is increasing over time. Agrin is a proteoglycan that plays an important role in the formation of neuromuscular junctions. It is generally
produced by adult SCs and is not necessarily associated with nerve injury.186 However, studies
of increased Agrin at the distal stump show that it is useful for preservation of the end organ. 181
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SCs cultured with the CSA and SCM showed slightly reduced release of GM-CSF, IL-6,
and INF-y at 48 hours compared to the TCP control. This is a potentially promising result as
these cytokines can serve as both recruitment factors, and M1 stimuli, for macrophages. Alternatively, the SCs cultured on the HA nanofibers had slightly increased release of several cytokines compared to the TCP control including ciliary neurotrophic factor (CNTF), IL-2, and tissue
inhibitor of metalloproteinases (TIMP)-1. Increased release of CNTF could be an exciting effect
of the fibers as CNTF promotes neuron survival and axon growth following injury.187 Furthermore, overexpression of CNTF can increase the expression of myelin proteins and direct differentiation in SCs.188 TIMP-1 complexes with matrix metalloproteinases to prevent their access to
bind protein substrates. TIMP-1 has a key role in controlling SC maturation and myelination following injury 189 and has also been shown to regulate maturation of oligodendrocytes in the
CNS.190 Agrin, IL-2, CNTF, and TIMP-1 are all interesting cytokines to explore with quantitative
ELISAs in the future.
Discussion
The primary objective of this study was to evaluate the ability of three specific biomaterials
cues, with established benefits for culturing DRG neurons in vitro 149, on two other key cell types
of the PNI microenvironment. Here we tested 1) chondroitin sulfate A (CSA) as a soluble, chemical cue, 2) processed porcine spinal cord extracellular matrix (SCM) as an adhesive substrate,
and 3) aligned hyaluronic acid (HA) electrospun nanofibers as a topographical cue for their ability
to create fast and/or lasting changes in macrophage and Schwann cell phenotypes. Chondroitin
sulfate proteoglycans, extracellular matrix, and the Bands of Bungner (these are aligned columns
of immature Schwann cells mimicked here by nanofibers) are endogenous biological cues present
following PNI that initiate repair programs. By providing these cues as a part of a scaffold, it could
be possible to accelerate these repair programs and recovery. The presence of the nanofibers
specifically could replace the need, to an extent, for SCs to align into a physical guide for regen-

84

erating axons. Consequently, the cells might begin their myelinating cascades sooner. An implantable scaffold, combining one or more of our cues, is the long-term goal of this research. Here
we’ve conducted an in vitro analysis of cell phenotype in response to each cue individually. We
found that the SCM and HA nanofibers direct both cell types towards regenerative phenotypes.
RAW 264.7 murine blood-derived macrophages were chosen as a representative macrophage cell line because their response to LPS is well-characterized in the literature 191, 192 making
them a predictable model for testing the effects of our cues. Additionally, the RAW 264.7 line has
long been established as a valid candidate for studying macrophage activation and function.193
Changes in the macrophages' morphology, cytokine release, and gene expression in response
to our cues were measured at 12, 24, and 48 hours following LPS activation. Here we aimed to
capture both an early cellular response (12 hours) and also to evaluate the ability of our cues to
successfully modulate cell phenotype in less than 48 hours before peak inflammation would occur.
iNOS and Arg1 fold changes, in all conditions tested, peaked at 12 hours, dropped by
~50% at 24 hours, and increased again at 48 hours. This oscillating and dampening pattern
matches a previous study showing that macrophages have an intrinsic “clock” that regulates
rhythmic gene expression and cytokine secretion upon LPS stimulation independent of systemic
cortisol.194 The SCM and HA fiber cues successfully reduced iNOS expression in LPS-treated
cells at 24 and 48 hours compared to LPS-treated cells on the TCP control. We predict that longer
time points would show a similar oscillating gene expression pattern with the SCM and HA fiber
cues further accelerating the macrophages return to a resting state.
The HA nanofibers also had the most significant effects on macrophage morphology and
were the only condition to suppress the typical LPS induced changes of increased cell area and
reduced cell circularity. However, the very rounded morphology of the cells on the HA nanofibers
was unexpected and spreading/elongation of the cells in the direction of fiber alignment would be
preferred. Hyaluronic acid is not an especially adhesive polymer. We predict that at longer time
points, as the cells lay down their own matrix proteins, the cells would begin to spread and align.
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Additionally, combining the fibers with the adhesive SCM (as we have done in our previous work)
is expected to further improve this morphological outcome.
Substrate mechanics also play an important role in macrophage polarization. Macrophages typically assume a spread morphology on stiffer substrates and maintain rounded morphology on softer ones.168 Our HA fibers have an approximate elastic modulus of ~1kPa 140. This
material is much softer than TCP or SCM-coated TCP and therefore stiffness likely contributed to
the rounded morphology observed on the fibers.
The immortalized S16 line was generated by repetitive passaging of primary neonatal rat
sciatic nerve and was first described in the late 1980s.195 S16s were chosen for this study because
they have previously been studied for their similarities to adult sciatic nerve, especially their level
of expression of myelin-associated mRNA and proteins.196 In the absence of axons, primary
Schwann cells rapidly become arrested and begin down-regulating many myelin constituents.
This limited number of cells makes functional, metabolic, and cell biology studies challenging. The
proliferating S16s are a practical alternative and several characterization studies concluded the
S16s are an appropriate model cell line, especially for the study of gene regulation.196, 197
Several studies have shown that activation of the Raf/ERK signaling pathway is sufficient
to drive dedifferentiation in Schwann cells.198-200 At the same time, other groups reported that LPS
treatment activates the Raf/ERK pathway in RSC96 Schwann cells201, a comparable line to
S16197, and primary Schwann cells.202 Given the results of these studies, we hypothesized that
LPS could be used to drive the cells towards immaturity/dedifferentiation through Raf/ERK signaling and that our biomaterial cues would direct and accelerate the cells towards a myelinating
phenotype. Unfortunately, LPS had no significant effects on gene expression or morphology of
the S16. Therefore, we tested the effects of the biomaterials cues on the SCs over time without
any LPS. We still hypothesized that our cues would induce markers of maturity/myelination in the
cells and our results support this hypothesis, especially for SCs cultured on the HA nanofibers.
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As with the macrophages, the HA nanofibers also produced the most significant changes
in the Schwann cells. The rearrangement of the cells’ cytoskeleton to elongate in the direction of
the fibers likely contributed to the observed differences in gene expression. Changes in SC gene
expression included significantly decreased GFAP (immature marker) and significantly increased
Oct6 and Krox20 (mature markers) at multiple time points. These results are very promising, especially considering the short culture period (significant changes as early as 24 hours). Previous
studies have also reported increased expression of myelin-associated genes in SCs when cultured on aligned PCL or poly-lactic-co-glycolic acid (PLGA) fibers but significant differences were
only achieved after 5-7 days in culture.81, 82 All changes, whether up or down, were on the order
of 2-fold which also matches these two earlier studies.
While the SCM coating had no significant effects on SC morphology, the SCM did have
interesting effects on SC gene expression. By 48 hours Oct6 was downregulated, while Krox20
was upregulated. Krox20 and Oct6 are often co-expressed during initial phases of myelination.
However, overexpression of Oct6 can lead to axonal death and therefore it is eventually turned
off, a process mediated by Krox20.203 The possibility that the SCM could direct the SCs towards
such an advanced stage of myelination is an interesting prospect and further evaluation of these
genes and their regulatory pathways is proposed future work.
Uncoated tissue culture plastic was selected as the control condition, rather than poly-Llysine coated TCP (as was used during S16 expansion), for several reasons. PLL was excluded
in the experimental tests primarily to 1) avoid a confounding chemical/adhesive cue presented to
the cells and 2) because we predicted that PLL would keep the cells in an immature state. Maintaining SC immaturity would be ideal for proliferation of the line, but in opposition to our goal of
directing SC maturation. PLL had the expected effects on the SCs including significantly decreasing expression of the mature marker Krox20. PLL also significantly influenced cell morphology
including increased cell area and reduced elongation. This unipolarized morphology is indicative
of SC immaturity.178 Lastly, the cytokine array results showed that SCs grown on the PLL had
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increased release of PDGF-AA, which is an SC autocrine signal for proliferation.204, 205 A summary
of PCR, morphology, proliferation and cytokine array results collected form SCs grown on PLL is
provided in Appendix B. PLL appears to keep the SCs in an immature phenotype which supports
our choice of experimental control.
Interestingly, the CSA had no statistically significant effects in any of our phenotypical
analyses for either cell type. Given that chondroitin sulfates are upregulated following PNI, it follows that they might be able to activate inflammatory programs in the cells. The lack of any CSAinduced changes is a promising result. Furthermore, our results suggest that CSA inhibits neuron
outgrowth via direct action on the neurons themselves rather than through modulation of the other
cell types.
There are now several great review articles available that discuss using biomaterials to
control M1/M2 activation.206, 207 Despite the vast amount of information now available on this topic,
there still exists a lack of exploration into naturally derived polymers, especially the hyaluronic
acid (HA) used here. Furthermore, while other groups have studied the effects of decellularized
ECM on macrophage activation state, including matrix derived from intestinal submucosa, urinary
bladder, brain, liver, skeletal muscle, and skin208, 209 this was the first look at the effects of ECM
specifically derived from spinal cord. Because of the challenges of processed whole nerve allografts, our precipitated SCM proteins provide ECM cues while the fibers can provide the structural
component. Here we wanted to delineate the effects of the different cues on the two cell types.
However, our results suggest that these two cues could work together synergistically to promote
pro-regenerative phenotypes in the macrophages and SCs.
Conclusions
This study adds to the growing collection of literature describing the important role of macrophage activation state for tissue regeneration following injury. This study offers a unique look at
macrophage phenotype in response to three cues not previously explored and offers a unique
perspective on macrophage phenotype in the context of a peripheral nerve injury. Furthermore,
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this study shows for the first time the influence of HA nanofibers, decellularized ECM, and soluble
CSA on Schwann cells specifically considering them as neuroimmune cells. Our spinal cord matrix and HA nanofibers successfully directed both cell types towards the intended phenotypes.
The use of a biomaterials to drive macrophages and Schwann cells to a pro-regenerative
and pro-myelinating state, respectively, has distinct advantages over previous approaches that
are pharmacologically dependent. Drug delivery faces many challenges such as maintaining continuous release at an efficacious dose and preventing unwanted clearance, diffusion, or tissue
uptake. Thus, the biomaterials-based approaches presented here could provide simpler translation to the clinic.
It is critical to evaluate the behavior of macrophages and Schwann cells in response to
tissue engineered scaffolds to ensure that the chemical and physical cues useful for neuron regeneration also facilitate the normal behaviors of these other repair cells. The approaches presented here could be used by other research groups to study their neural tissue engineered systems and hopefully improve the success of nerve guide conduits in vivo.
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CHAPTER 5: CONCLUSIONS, FUTURE WORK, AND LONG-TERM GOALS
In the preceding chapters, we have presented several approaches to understanding and
engineering the injury microenvironment to improve peripheral nerve regeneration. In Chapter 2,
we provide quantified neurite extension and retraction data in response to multiple cues, especially ‘negative’ Chondroitin sulfate A (CSA). We describe a method for evaluating receptor expression in dorsal root ganglion (DRG) neurons using flow cytometry and provide the first report
of the influence of CSA on Syndecan-3. Finally, we demonstrate the ability of a novel biomaterial,
isolated porcine spinal cord matrix (SCM), to increase neurite outgrowth through reduced growth
cone stalling.
In Chapter 3, we describe methods for methacrylating CSA to CSMA and electrospinning
it into nanofibrous scaffolds. Additionally, we describe electrospinning blended scaffolds of SCM
and methacrylated hyaluronic acid (MeHA). This is the first report of CSMA and MeHA, and SCM
and MeHA, utilized together as electrospun scaffolds for neurite growth. These scaffolds feature
two key adhesive cues that successfully improved neurite outgrowth over controls.
In Chapter 4, we explore the ability of CSA, SCM and MeHA nanofibers to modulate the
phenotype of other cells in the peripheral nerve injury (PNI) environment. We describe changes
in macrophage and Schwann cell morphology, gene expression, and cytokine release over a twoday period following activation of the cells to an injury mimicking state. Our biomaterials cues
successfully directed both cells towards pro-regenerative phenotypes (macrophages towards M2
and Schwann cells towards maturation). More importantly changes happened in as little as 24
hours, much faster than other studies have reported.81, 82, 210, 211 These changes were induced
without pharmacological agents as most often described by others.212, 213 Changes induced by
implantable biomaterials rather than diffusible drugs should make for easier and more successful
clinical translation. Taken together, our results provide foundational work for creating a single
scaffold system, combining multiple biomaterials cues, that could work synergistically to accelerate repair programs in larger peripheral nerve gaps.
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Current treatments, including coaptation, autografts and allografts, are insufficient to
achieve full functional recovery in large peripheral nerve injuries (transection gaps >3cm). Tissue
engineered nerve guide conduits (NGCs) have remained the most promising alternative treatment
since their introduction in the clinic in the early 1980s.40 The typical NGC is a basic, hollow tube
into which the two nerve ends are sutured. Unfortunately, currently available NGCs are still hollow.
They lack the necessary internal chemical and physical cues to direct axon regeneration.
Short peripheral nerve injuries (<3cm) have great regenerative capacity due to a unique
environment that forms following injury. This regeneration program includes de-differentiation,
hyperproliferation, and alignment of resident Schwann cells (SCs) into “bridges” (called the Bands
of Bungner) that span the gap and provide a substrate for regenerating axons. The Schwann cells
also release cytokines to recruit macrophages to the injury site. Pro-inflammatory macrophages
initially clean up axonal and myelin debris but transition their phenotype towards a pro-healing
state at later stages of repair. The Bands of Bungner take up to 4 days to form and can persist for
over 25 days following injury.214, 215 The average rate of neurite extension (2-5 mm/day in humans)
would allow for axons to cross a 3cm gap in this time frame. In large gaps, however, the Bands
of Bungner often fail to form completely. A chronic condition develops where Schwann cells remain de-differentiated, macrophages remain pro-inflammatory, and regenerating axon bundles
form disorganized neuromas. These patients suffer long-term pain and limited function at their
injury site.
Over the past 30 years, several tissue engineering groups have attempted to modify the
basic NGC. Modifications include changes to conduit porosity/permeability, material conductivity,
growth factor delivery, exogenous cell delivery, and luminal channels. Unfortunately, NGCs, even
with these modifications, often fail to match controls (autografts) in animal models.7, 43 Several
examples of these approaches are described in more detail in earlier chapters where we also
suggest that current strategies fall short of full repair because of several gaps in the literature.
Some of those gaps include understanding the response of neurons to inhibitory cues at the injury
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site (e.g. chondroitin sulfate proteoglycans), quantifying real time neuron behavior in response to
different cues, exploiting inhibitory cues in scaffold systems, and studying the effect of tissue
engineered scaffolds on the other repair cells (macrophages and Schwann cells).
One of the primary goals of this thesis was to study the intrinsic PNI repair environment
and to design biomaterials cues that could mimic the Bands of Bungner. We studied both permissive and inhibitory cues present following injury. Effects were studied not only on neuron behavior
but especially the behavior of macrophages and Schwann cells. Another key goal was acceleration of the repair programs since time is of the essence in large nerve gaps. The experiments
presented here serve as promising tools for studying the PNI environment in vitro. We want to
further improve this work to be a true PNI model. We want to continue elucidating important repair
receptors, monitoring cell behaviors, and identifying key genes and cytokines involved in the repair process. Furthermore, we want to adapt the model to incorporate more and different cells.
Below are a few specific experiments that we would explore next.
In this thesis, we successfully define a method for measuring receptor expression in DRG
neurons using flow cytometry and demonstrate for the first time that CSA can induce an increase
in Syndecan-3 receptors. We propose to expand this investigation to include the other 3 members
of the Syndecan family, which have all been investigated for their roles in the nervous system. 216
Murakami et al. showed that 7 days post op, peripheral motor neurons in mice had significantly
increased Syndecan-1 expression in the cell bodies and terminals of the regenerating nerve fibers
compared to uninjured control neurons.217 Syndecans-2/4 has been shown to mediate growth
promotion of PC12 cells by binding different laminin peptides.218, 219 We also propose using identification and neutralization antibodies for all 4 of these receptors in combination with time lapse
microscopy to confirm their potential roles in neurite extension and retraction. We also propose
to confirm the ability of the methacrylated CSA (CMSA), especially when electrospun into nanofibers, to retain its effects on SYN-3 expression in the neurons. Our flow cytometry methods could

92

be adapted to test a wider variety of receptors in DRG neurons, other neuronal populations, or
even the other cell types of the injury environment including SCs and macrophages.
Based on our results from Chapter 2, we recommend a push towards increased video
microscopy during experiments involving neurite regeneration. It is especially important to consider not only neurite extension, but stalling and retraction as well in response to different biomaterials. We expect that this could improve development of future tissue engineered treatments
for PNI. Interesting future work could also include using time lapse imaging to monitor physical
changes (e.g. morphology and migration) in macrophage and Schwann cell phenotype over
time.220 Direct co-culturing of neurons with one or both cell types described here would be ideal
but time lapse imaging could present a significant challenge. A possible alternative would be to
test the effect of conditioned media from the macrophages, Schwann cells, or co-cultures of both
cell types for influencing neurite outgrowth on the scaffolds. Another important cell type releasing
factors into the injury environment to promote and direct regeneration are cells of the end organ,
for example muscles innervated by motor neurons. End organ responsiveness is increased following nerve injury but the role of CSA on these cells has not been well characterized. The effects
of our materials on end organ responsiveness would be an interesting future step. As well as coculture of the neurons with injured myocytes.
Long-Term Goals
The next steps suggested above are designed to fine tune our model of the PNI environment to further improve in vitro testing before moving in vivo. The long-term goal of this research,
however, is better treatment of large peripheral nerve gaps in the clinic. We ultimately aim to
produce a scaffold system that mimics the Bands of Bungner and is an off-the-shell conduit filler
that could be implanted inside commercially available devices during normal PNI surgeries. We
believe this thesis has successfully evaluated tools that could be combined into such a device for
use in vivo. To move our materials to animal models and ultimately the clinic, the 2D nanofibers
would be formed into 3D cylindrical bridges that could be assembled inside of an implantable
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device. To form these 3D bridges, we would use the electrospinning technique described for creating 2D sheets of nanofibers but with a longer spin time to achieve thicker scaffolds. Scaffolds
could then be rolled into a cylindrical "bridge." Target diameter of ~1 mm and a minimum of length
of 3 cm for these “bridges” represents the size order and length needed for a large nerve gap.
Several bridges could be inserted into an existing NGC depending on the diameter of the injured
nerve. Peripheral nerve diameters typically range from 1 to 10 mm, but may be as large as 20
mm in the sciatic nerve.30 Consequently, size mismatch between the injured nerve and donor
nerve is a common obstacle to nerve autograft and allograft treatments. This proposed system,
in combination with an NGC, could help combat this drawback of grafting.
We anticipate that the bridges could be sutured directly to the nerve stumps using the
same suture materials and methods for securing the current conduits into place. However, to
avoid introducing additional damage at the repair site with this added suturing, the bridges could
also be suspended in place with an injectable gel. Although not presented here, we have previous
experience fabricating hyaluronic acid and collagen hydrogels. These gels could be used to embed the electrospun “bridges”. Furthermore, the SCM, used here as an adhesive coating or
blended into nanofibers, could also serve as the gel material. Solubilized matrix could be crosslinked using varying concentrations of cytocompatible genipin (0-5mM). Genipin could be mixed
into the spinal cord matrix solution and injected into and around the artificial bridges, which once
crosslinked, would hold the bridges in place. Furthermore, we have already demonstrated the
neurite growth promoting capabilities of the matrix itself. Figure 5-1 illustrates a proposed nerve
guide conduit design. By mimicking the Bands of Bungner that form during regeneration, as opposed to creating open channels, issues such as channel collapse and poor neurite infiltration are
eliminated as the bridges are designed to support axon elongation around and on their surface.
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Figure 5-1. Proposed incorporation of HA nanofibers and SCM into a nerve guide conduit
A cross-section illustrating the proposed design of using aligned fibers to mimic the Bands of
Bungner/Schwann cell cables that form following injury. The lime green color represents material
to be determined, such as HA or collagen hydrogel, or crosslinked spinal cord matrix.

Applications in the Central Nervous System
The experiments in this thesis were specifically designed to explore the native repair processes and environment provided to regenerating peripheral axons. We explore using soluble
and adhered, permissive and inhibitory biomolecules and nanofibers. However, these experiments are clearly relevant for testing the extension and retraction behavior of spinal neurons in
response to topographical and adhesive cues as well. The MeHA nanofibrous scaffolds can provide a substrate for regenerating axons following SCI. Furthermore, it is possible that our scaffold
design would be able to induce phenotypical changes in the glia of the central nervous system
(CNS), particularly astrocytes, but also oligodendrocytes (the myelin producing cells of the CNS)
and microglia (CNS inflammatory cells), leading to the same accelerated repair that we aimed for
in the PNS.
Schwann cells are essential for the regeneration and remyelination of axons following injury in the PNS. Recent studies have also shown that transplantation of Schwann cells is a promising therapy for spinal cord repair.221, 222 When transplanted into injured spinal cord, a Schwann
cell suspension provides trophic support for the regenerating axons. For the Schwann cells to

95

guide axonal regeneration as a substrate, however, these support cells must be able to proliferate,
migrate, and align within the injury site themselves.223 This process could fail in a SCI in the same
way that the Bands of Bungner are often disorganized or absent in large peripheral gaps.
Whole peripheral nerve grafts have also been used to treat spinal cord injuries with considerable success

224, 225

. These results demonstrate that central neurons do not possess a fun-

damentally different intrinsic ability to regenerate than peripheral neurons. Rather, the substrate/environment provided by the peripheral nerve graft is of critical importance to axonal regeneration. Therefore, we propose applying the scaffold components describe here to the treatment of CNS injuries, especially spinal cord injury (SCI). Schwann cell cables provide for greater
flexibility in nerve repair than transplants of whole peripheral nerves as well.226 A Schwann cell
cable mimic could be applied to the spinal cord injury site replicating several of the cues required
of all regenerating axons regardless of location.
In this thesis, we studied axon retraction which is an early feature of nearly all neurodegenerative diseases (NDs) including Alzheimer's disease (AD), Parkinson's' disease (PD), Huntington's disease (HD), Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS) and more.118
Combined prevalence of these NDs in the United States exceeds 240 persons per 10,000 as of
2013 (NCHS; NINDS). These and other NDs contribute an estimated $150-200 billion burden to
US healthcare annually.227 Thus the NDs are of particular scientific and clinical interest because
of their increasing medical and societal impact.
One issue associated with current ND treatments is increased activation of the microglia.
Reducing this activation, and inducing the microglia back to a homeostatic phenotype, with topography and/or adhesive cues on a nanofibrous scaffold, as we've described for macrophages
in Aim 3, could also potentially be applied in the brain. In addition, myelin loss is the hallmark of
multiple sclerosis. Investigating methods to induce oligodendrocytes into a pro-myelinating phenotype, such as with the topographical approach described here for Schwann cells, might have
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potential for treating this disease. An implanted biomaterial scaffold would be a novel treatment
option for NDs.
Summary
In a 2009 Nature Review, the regenerating growth cone is compared to a "vehicle" as it
encounters many different types of cues. The "vehicle" moves along a "road" of adhesive molecules either presented by neighboring cells or assembled into the extracellular matrix. Anti-adhesive, surface bound molecules, can inhibit the advancement of the growth cone acting as "guard
rails" or boundaries. Finally, diffusible chemotropic cues represent "road signs" that present further steering instructions to the growth cone.13 In this thesis, we explored elements of the “road”
(SCM and MeHA nanofibers), “guard rails” (CSMA), and “road signs” (CSA) for their effects on
real time neurite behavior and macrophage and Schwann cell phenotype. We aim to engineer
better strategies for neural tissue regeneration through deeper understanding of the injury environment and cellular responses to it.
We highlight several tools for studying and manipulating the PNI environment including:
flow cytometry, PCR, antibody arrays for cytokine release, time lapse microscopy, fluorescence
microscopy, topographical cues created by blend electrospinning (and early potential for dual
electrospinning see Appendix B), unique biomaterials cues (soluble CSA, immobilized CSMA,
MeHA, SCM as coating and fibers). We applied these tools to several cell types in the PNI environment looking to direct cell responses. The response that we see from the cells are promising
results that can lead us to the recommendation that these tools be applied to more cell types (ie.
CNS), to combinations of different cell types (direct co-culture or conditioned media) and to evaluate NTE scaffolds in greater detail in vitro prior to moving to in vivo models which are potentially
more expensive and time consuming. We want neural tissue engineered scaffolds to succeed in
treating large peripheral nerve gaps. We hope that this thesis can serve as a guideline in the
design of other tissue engineered systems and we hope the specific biomaterials explored here
will find widespread application in the nervous system.
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APPENDIX A: Preliminary Gradient Scaffolds
The ability of soluble and adhered biomolecular gradients to direct neurite outgrowth and
growth cone turning has been well established over the last few decades. Furthermore, tissue
engineered gradients have become an increasingly popular paradigm for improving axon regeneration following peripheral nerve injury as well as for directing other types of cell migration.62 This
appendix contains preliminary work on creating gradients within our nanofibrous scaffolds using
a dual needle electrospinning apparatus.
Polymer Synthesis and Modification
The goal of this work is to deliver molecular gradients of methacrylated Chondroitin Sulfate
A (CSMA) and porcine spinal cord matrix (SCM) within our methacrylated hyaluronic acid (MeHA)
scaffolds. We previously demonstrated the ability of each of these cues to promote neurite outgrowth individually (see full Methods and Results in Chapter 3). However, in this preliminary work,
we have formed gradients of the amino acid sequence RGD (Arg-Gly-Asp) using a method previously described for RGD conjugation to MeHA.228 Briefly, cysteine-containing RGD peptides
(GCGYGRGDSPG, Genscript) were conjugated to the MeHA via a Michael's addition reaction
between thiols on the peptides and methacrylates on the MeHA. The RGD peptide (1mM) and
MeHA (2% w/v) were reacted overnight in triethanolamine buffer (pH 8), dialyzed against DI H2O
for 48 hours, and lyophilized to obtain MeHA+RGD. Un-conjugated methacrylate sites can be
linked to one another in the presence of Irgacure 2959 photocrosslinker and UV light to introduce
crosslinks that will stabilize the material. Figure A-1 illustrates the MeHA synthesis and peptide
modification reactions.
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Figure A-1. MeHA synthesis and RGD conjugation.
Methacrylate side groups are added to hyaluronic acid using a Michael’s addition reaction. Methacrlyate groups serve as attachment sites for the RGD peptide. Unmodified methacrylate sites
are linked to one another in the presence of Irgacure 2959 photocrosslinker and UV light.

Nuclear Magnetic Resonance
Proton nuclear magnetic resonance (NMR) with a Bruker Avance 700 MHz biomolecular
NMR was used to assess methacrylation and RGD attachment to the HA following a previously
published protocol.229 Briefly, samples were dissolved at 5 mg/mL in D2O (Sigma) and the degree
of methacrylation was calculated from the NMR spectra as the ratio of the acetylenic protons from
the methacrylate groups to the N-acetyl methyl protons from the HA backbone. Figure A-2 shows
NMR spectra collected for two different degrees of HA methacrylation and the MeHA+RGD.
These spectra suggest that our methacrylation and peptide modification of the hyaluronic acid
was successful. A reaction of 1.11 mL of methacrylic anhydride per gram of HA (Figure A-2C)
produced ~10% modification, while 2.22 mL of MA per gram of HA (Figure A-2B) produced ~25%
modification. Figure A-2A shows the higher modification MeHA conjugated with 1mM of RGD
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peptide. The two peaks at 3.3 and 3.7 ppm are indicative the H and H of the Arginine amino
acid, respectively (Biological Magnetic Resonance Data Bank, http://www.bmrb.wisc.edu/).

Figure A-2. NMR spectra
The degree of methacrylation is calculated as the ratio of the areas under the proton
peaks at 5.6 and 6.1 ppm (acetylenic protons from the methacrylate groups; 1 and 2) to
the peak at 2 ppm (N-acetyl methyl protons from the HA backbone, 4).

Electrospinning Gradient Scaffolds
Following synthesis and peptide modification, the following polymer solution was prepared
for electrospinning: 2 wt% MeHA+RGD, 3 wt% polyethylene oxide (PEO, MW 900 kDa, Sigma),
and 0.05 wt% Irgacure 2959 photoinitiator (BASF) in DI H2O. Electrospinning apparatus parameters including flow rate, needle gauge, voltage, collection distance, and collection surface/mandrel
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dimensions are provided in detail in Chapter 3 and have been adapted from Ifkovits et al 2009.
Fibers were collected for 45 minutes (~50μm thick layer) and crosslinked onto methacrylated
glass coverslips. Chapter 3 also contains fiber crosslinking, and rinsing methods.
The RGD peptide sequence, derived from fibronectin, is a ubiquitous adhesive cue for all
cells. By distributing the RGD in a controlled gradient, the direction of neurite growth can also be
controlled. Scaffolds featuring gradients of the RGD peptide were produced by electrospinning
two different solutions from needles placed on either side of the spinning mandrel. Mandrel rotation speed was used to form aligned (~2500 rpm) and non-aligned (~700 rpm) nanofibers. The
electrospinning set up is illustrated in Figure A-3 where Polymer A = MeHA with RGD peptide
and Polymer B = MeHA without RGD peptide. The offset distance (‘x cm’) between the two needles was varied to alter the resulting gradient shape.

Figure A-3. Schematic of the dual needle electrospinning set up for creating fiber gradients
(A) Schematic of the apparatus used to electrospin gradient scaffolds. (B) Resulting gradient obtained with 4cm offset. Percentage of each type of fiber was measured using relative fluorescence
of DAPI and Rhodamine stains. (C) Fluorescent micrographs of fibers obtained at 3 different positions evenly spaced along the gradient. Scale = 200 μm.
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RGD Distribution
To estimate RGD distribution in the gradients, the RGD containing polymer solution was
mixed with Rhodamine B (25 μM) prior to spinning and the resulting gradient shape was analyzed
using relative fluorescence intensity measurements. The distribution of dyed fibers was used to
estimate the spatial distribution of the RGD peptide. 2, 4, 6 and 8 cm offsets between the two
needles were tested for producing differently shaped RGD gradients spun onto 22x22mm coverslips centered between the two needles. The 4cm offset was chosen for the subsequent cell
studies because it produced the most linear gradients (see Figure A-4) whereas a 2cm offset
resulted in a more uniform RhoB distribution and 6 and 8 cm offsets resulted in step-like gradients.

Figure A-4. RGD gradient distribution estimated from Rhodamine B fluorescence intensity
Top: Fluorescent image showing the distribution of Rhodamine B across the width of the nanofiber scaffold (spun with a 4cm needle offset). Bottom: Measured fluorescence intensity across
the scaffold. n = 12 scaffolds. Mean  SEM.
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We hypothesize that opposing linear gradients of our two target cues (CSMA and SCM)
will produce the most directed neurite outgrowth based on the success of other studies that investigated linear gradients of soluble and adhered biomolecules for directing neurite growth (Table A-1). However, many different gradient shapes can be produced with the different needle
offset distances. Therefore, many different shapes should be tested in order to optimize the behavior of the DRG neurite outgrowth on the CSMA and SCM gradients, because these two molecules have previously not been tested as gradients for controlling neurite outgrowth.
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Cell Type

Gradient
Molecule

Threshold Required for
Neurite Orientation
(Slope)

Increased
Neurite
Growth
Rate?

Directed
Neurite
Turning?

References

PC12

NGF

0.133 μg/mL/mm

U

U

230

Chick Embryo DRGs

NGF

0.133 μg/mL/mm

U

Y

231

NGF
NT-3
EGF, FGF2
and PDGF
Netrin-1
(attractant)
Slit-2
(repellent)

0.08 μg/mL/mm
0.08 μg/mL/mm

U

Y

231

Nonea

Y

U

232

1 μg/mLb

U

Y

0.250 μg/mLb

U

Y

NGF

U

Y

Y

233

Netrin-1

U

Y

U

234

NT-3

U

U

Y

235

Laminin

60 μg/mL/μm

N

N

236

Rat PC12

NGF

0.137-0.357 μg/mL/mm

U

U

237

Chick Embryo DRGs

IKVAV

U

Y

Y

50

Chick Embryo DRGs

NGF

0.31 μg/mL/mm

U

U

238

NGF
NT-3
IKVAV
YIGSR
Laminin-1
Isoform

0.2 μg/mL/mm
0.2 μg/mL/mm
7.44 µg/mL/mmc
14.9 µg/mL/mmc

U

U

238

Y

N

239

Y

N

153

Chick Embryo DRGs
Human Neural Stem
Cells
Mouse Hippocampal
and DRG Neurons
Rat DRGs
Rat Hippocampal
Neurons
Rat Dorsal Column
Lesions
Rat Hippocampal
Neurons

Chick Embryo DRGs
Chick Embryo DRGs
Chick Embryo DRGs
Chick Embryo DRGs
Mouse NSC-34
Hybrid Cell Line and
Dissociated Rat
Spinal Cord Neurons
RSC-96 Rat Schwann
cells

63

0.017 μg/mL/mmc

PSA

U

Y

U

HNK-1

U

N

U

PSA

U

Y

U

HNK-1

U

Y

U

PSA/HNK-1

U

Y

U

PSA

U

Y

U

HNK-1
PSA/HNK-1

U
U

N
Y

U
U

240

240

240

Table A-1. Neural Cell Responses to Soluble and Immobilized Chemical Gradients
Y = yes; N = no; U = unreported/unavailable; a In the concentration range 0–40 ng/mL over a 2.4mm
distance, nonlinear slope. b Across 1.2mm distance, nonlinear slope. c These values do not represent threshold conditions but rather indicate optimal gradient slopes for maximizing outgrowth.
PSA/HNK-1 in a 50/50 ratio. Green shaded cells = soluble/chemotactic gradients; Blue shaded cells
= immobilized/haptotactic gradients
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Gradient Scaffolds for Cell Studies
Scaffolds featuring non-aligned fibers with a gradient of RGD (Figure A-5A) were combined with a thin layer of aligned, unmodified fibers in order to assess the additive effect of the
adhesive gradient and fiber alignment cues (Figure A-5B). Non-aligned scaffolds with a thin layer
of aligned fibers, but no RGD, were used as a control (Figure A-5C). Whole dorsal root ganglia
(DRG) from chick embryos were grown on the scaffolds for 3 days in serum free media and fixed
and stained as described in Chapter 3. Figures A-5D, E and F show examples of DRGs grown
on each of the three scaffold types, respectively.

Figure A-5. Gradient scaffold schematics and fluorescence micrographs of DRG outgrowth
A ,B, C) Schematic representations of the non-aligned (NA) gradient, layered gradient, and layered control scaffolds, respectively. Green indicates the direction of increasing RGD peptide. D,
E, F) Resulting DRG outgrowth on the corresponding gradient and control scaffolds after 3 days.
DRGs stained with anti-neurofilament (green) and DAPI (blue). Scale = 500 μm.
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NIS Elements and ImageJ software were used to quantify whole DRG outgrowth using
two different ratios (Figure A-6):
•

Gradient ratio was used to measure the influence of the RGD peptide. The yellow

dashed line represents the area of the DRG body (DAPI staining/blue pixels). The centroid of this
area was used to divide the image in half (solid yellow line) so that either side contained an equal
area of the DRG body. Next a custom Matlab script was used to measure the area of the neurite
outgrowth (FITC staining/green pixels). Briefly, the code uses an automatic threshold to convert
a grayscale image to binary and then sums the pixels to quantify the outgrowth area. The ratio of
axon outgrowth of the right side to the left side of the image was calculated. A ratio of >1 indicates
neurite outgrowth was greater towards the increasing RGD peptide.
•

Modified aspect ratio was used to measure the influence of fiber alignment. Auto

edge detection was used to measure outgrowth in the left/right direction (direction of the gradient
and/or fibers) divided by the outgrowth in the top/bottom or perpendicular direction. The red lines
in Figure A-6 show an example of these two measurements.
All outgrowth was normalized to body size for each individual DRG.
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Figure A-6. Measurement techniques and growth ratios of DRGs on gradient scaffolds
Top: Area of outgrowth up (green) or down (red) the gradient of RGD was compared.
Bottom: Sample image of a DRG showing division of the body area for gradient ratio (yellow
lines) and maximum outgrowth measurements (red lines) for the modified aspect ratio.
Scale = 500 μm.

Scaffolds featuring gradients of RGD peptide produced a ~20% increase in neurite growth
towards the direction of increasing RGD over the control scaffold, but the difference was not statistically significant. Furthermore, there was no statistical difference between groups with and
without the top layer of aligned fibers. Aspect ratio data revealed that the presence of the aligned
fibers significantly increased neurite outgrowth in the fiber (left/right) direction over the nonaligned RGD gradients for both scaffolds with and without RGD. Furthermore, scaffolds with RGD
and an aligned fiber layer showed the most overall growth area (data not shown) suggesting a
possible additive effect of these two cues. Figure A-7 quantifies the results of the DRG outgrowth
on the gradient scaffolds.
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Figure A-7. Quantified outgrowth from DRGs cultured on the gradient scaffolds
Top: Aspect ratio results. * p < 0.01, one-way ANOVA, Tukey post hoc. Bottom: Gradient ratio
results. 3 trials, 3 repeats per condition per trial. n = 9 DRGs measured per condition.

Summary
In this preliminary work RGD peptide was used as an example molecule for creating gradient scaffolds. In the future, the techniques described above could be adapted to deliver the
neural specific guidance molecules characterized in this thesis, chondroitin sulfate A and the spinal cord derived matrix. Gradient scaffolds could be delivered in vivo to guide growth from the
proximal to distal or distal to proximal nerve stumps. The proposed design, featuring dual gradients of both positive and negative adhered guidance molecules, would be a novel approach to
controlling the directedness of neurite outgrowth. During nervous system development, chondroitin sulfate proteoglycans (CSPGs) guide neurons to appropriate targets by inhibiting them
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from entering inappropriate ones.28 Our design would exploit the ability of CSPGs to direct neurite
outgrowth by avoiding inefficient regeneration, such as misdirected or “wrong way” axons and/or
excessive neurite branching. We are especially interested in directing, continuous persistent neurite outgrowth across large peripheral nerve gaps to accelerate repair.
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APPENDIX B: Chapter 4 Supplement
Appendix B contains supplementary data and figures from Chapter 4.

A

B

Figure B-1. Cytokine array maps
Array maps show the position and number of replicates for each cytokine assayed for release from
the RAW 264.7 macrophages (A) and S16 Schwann cells (B) in response to our biomaterials cues.
Positive Controls (POS1, POS2, POS3) are equal amounts of biotinylated IgGs printed directly onto
the array their intensities should be the same for each sub-array. Negative Control (NEG) spots are a
protein-containing buffer. Their signal intensities represent non-specific binding of Biotin-conjugated
anti-Cytokines and/or Streptavidin-Fluor. Controls allow for normalization based upon the relative fluorescence signal responses to a known control. CINC1 = CXCL1 (human GRO-α homolog), CINC2a
= CXCL3 (human GRO-γ homolog), CINC3 = CXCL2 (human GRO-β homolog), FASLG = Fas Ligand,
CX3CL1 = Fractalkine, CSF2 = GM-CSF, LIX = CXCL5, SELL = L-Selectin, PRLR = Prolactin Receptor, RAGE = Receptor for Advanced Glycosylation Endproducts, CXCL7 = Thymus Chemokine 1;
VEGF-A detects VEGF(165 aa) and VEGF(121 aa); B7-2 / CD86, PRLR and RAGE detect soluble
forms of these proteins.
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Figure B-2. Macrophage cytokine array images
Laser scanning and data extraction provided by RayBiotech. Headings indicate biomaterial cue being
tested and time point in hours. DMEM = media only control/no cells; TCP = tissue culture plastic; LPS
= Lipopolysaccharide 1μg/mL; CSA = chondroitin sulfate A at 10μg/mL; SCM = spinal cord matrix
coating 5μg/cm2; HA fib = hyaluronic acid nanofibers.
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Figure B-3. Schwann cell response to LPS treatment
LPS had no statistically significant effects on mRNA expression (A) or morphology (B) of the S16
Schwann cells. Significance considered p<0.05 one-way ANOVA + Fisher’s LSD post hoc.
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Figure B-4. Schwann cell phenotype on PLL: PCR and Morphology
Poly-L-lysine (PLL) keeps the S16 Schwann cells in an immature state based on statistically significant
differences in mRNA expression (A) and morphology (B) compared to cells grown on TCP without
PLL. *p<0.05 one-way ANOVA + Fisher’s LSD post hoc.
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Figure B-5. Schwann cell phenotype on PLL: Proliferation and Cytokine Release
S16 Schwann cells cultured on poly-L-lysine (PLL) have increased proliferation (A) and differences in
cytokine release (B) compared to SCs grown on TCP without PLL.
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Figure B-6. Schwann cell PCR results
S16 mRNA expression of key markers of
maturation/myelination 12 (A), 24 (B), and 48
(C) hours following culture with the indicated
biomaterials cues. Fold changes reported
relative to TCP control and normalized to
beta-actin. Mean ± SEM. N = 3 biological replicates. * p<0.05 one-way ANOVA + Fisher’s
LSD post hoc.
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Figure B-7. Schwann cell cytokine array images
Laser scanning and data extraction provided by RayBiotech. Headings indicate biomaterial cue being
tested and time point in hours. DMEM = media only control/no cells; TCP = tissue culture plastic; PLL
= poly-L-lysine; CSA = chondroitin sulfate A at 10μg/mL; SCM = spinal cord matrix coating 5μg/cm 2;
HA fib = hyaluronic acid nanofibers.
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ABSTRACT
BIOMATERIALS APPROACHES FOR UTILIZING THE REGENERATIVE POTENTIAL
OF THE PERIPHERAL NERVE INJURY MICROENVIRONMENT
by
MELISSA RENEE WROBEL
August 2017
Advisor: Dr. Harini Sundararaghavan
Major: Biomedical Engineering
Degree: Doctor of Philosophy
Clinically available treatments are insufficient to achieve full functional recovery in large
(>3cm) peripheral nerve injuries (PNI). The objectives in this thesis were 1) to study often overlooked elements of intrinsic PNI repair including release of inhibitory CSPGs and post-injury responses of inflammatory macrophages and dedifferentiated Schwann cells; 2) to create biomaterial scaffolds featuring topographical and adhesive cues to enhance neurite outgrowth; and
3) to test the ability of those cues to direct macrophages and Schwann cells towards a pro-regenerative phenotype. It is hypothesized that recapitulating the positive and negative cues of the PNI
microenvironment can better improve regeneration. The effect of a characteristic CSPG, Chondroitin Sulfate A (CSA), was tested on neurite dynamics of dissociated chick embryo dorsal root
ganglion (DRG) neurons using time lapse video microscopy. DRG growth was recorded on different adhesive substrates, including a novel, porcine-derived spinal cord matrix (SCM). The SCM
significantly increased neurite extension, reduced neurite stalling, and mitigated CSA inhibition.
Flow cytometry was used to measure changes in cell-substrate binding receptor expression in
the neurons. Results showed a significant increase in Syndecan-3 receptor expression in neurons
treated with CSA, suggesting a possible priming of the cells for regrowth. The CSA was successfully immobilized within electrospun hyaluronic acid (HA) nanofibers using a methacrylation reaction. Blended electrospinning was used to create scaffolds featuring the CSA and SCM cues.
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Results showed significantly increased neurite outgrowth on scaffolds with the SCM and low levels of CSA. Higher incorporation of CSA maintained its inhibitory properties. Next the CSA, SCM,
and HA fiber cues were tested for their effects on macrophage and Schwann cell phenotype. It
was hypothesized that one or more of the cues would accelerate the macrophages return to rest
following classical activation (M1/pro-inflammatory) with lipopolysaccharide (LPS; 1μg/mL) and
would accelerate the transformation of Schwann cells from an immature state following injury to
a mature/pro-myelinating one. Cell phenotypes were functionally assessed using quantified reverse transcription polymerase chain reaction (qRT-PCR), immunofluorescence, and sandwichELISA based antibody arrays to measure changes in mRNA expression, morphology, and cytokine release, respectively. Macrophages cultured with the SCM and HA fibers had significantly
reduced M1 gene expression, released lower levels of M1 cytokines (IL-1a, RANTES and TFNa) and assumed an elongated morphology indicative of M2. These cues also induced changes in
the Schwann cells including significantly reduced area, increased elongation, decreased expression of immature genes (GFAP) and increased expression of mature genes (Krox20 and Oct6).
These results suggest that the SCM and HA nanofibers could trigger non-neuronal cells towards
regenerative programs more quickly than traditional PNI interventions. Changes induced by biomaterials have distinct benefits over the use of immunomodulatory cytokines and would be a
novel approach to direct repair. Our collective studies offer improved insight into the endogenous
potential of the injured peripheral nerve and offer ways to incorporate intrinsic repair cues into a
biomaterial system for treating large gaps.
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